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Proximity ligation assays are powerful tools for sensitive detections of proteins. These assays 
are usually performed with two DNA-tagged aptamers or antibodies binding at proximity to 
each other on the same protein or interacting proteins. Thanks to the proximity between these 
two probes, the DNA tags can be ligated and the resulting sequence can be amplified by PCR. 
Many copies of the target sequence are thus generated and the labelling of this sequence will 
result in a signal high enough to enable sensitive and robust detection of proteins or/and protein 
complexes.[1, 2] 
 
The aim of the first project described in the present thesis was to investigate whether the so-
called click reaction, could contribute to the development of the existing PLA methods.  
Therefore, we imagined as a proof of concept a model where three click functional 
oligonucleotide probes are hybridized next to each other on a single longer oligonucleotide. 
Upon hybridization on the latter one thus designated as the template, the probes could be 
conjugated by clicking with each other.  
 
The first part of the project was to envision the synthesis of oligonucleotide probes with the 
desired click functional groups with reliable, effective and easy to perform protocols. As a 
starting point and based on previous work achieved in the Carell group, we used DNA strand 
with one alkyne-modified nucleoside incorporated by automated solid phase synthesis.[3] In 
order to subsequently functionalize oligonucleotides with one or two azido-groups from the 
single alkyne modification, we decided to rely on a chemoselective strategy (Figure 1A). It has 
been reported that chelating azides such as picolyl azide are significantly more reactive than 
non-chelating azides towards CuAAC reactions.[4] This difference in reactivity is such that on 
small molecules bearing both a picolyl azide and a normal azide, the picolyl azide can be 
clicked selectively to an alkyne molecule.[5] The non-chelating azide is thus left unreacted and 
available for a second click reaction. Here, we examined if this strategy could be applied to 
longer linkers to match our needs. Therefore, we synthesized two unsymmetrical linkers; a first 
one with one picolyl azide and one non-chelating azide and a second one with one picolyl azide 
and two non-chelating azide. These linkers were effectively and with very good selectivity 






one or two azido-groups. Next, we applied a sequential strategy to obtain oligonucleotides with 
long alkyne functions. The idea here was to synthesize unsymmetrical linkers with one azide 
at one extremity and one or two protected alkynes on the other extremities. Following the 
conjugation of these linkers by CuAAC to alkyne modified DNA strands, the protecting 
group(s) of the alkyne of the linkers was removed leaving it free for further reactions (Figure 
1B). This method also proved to be fast, reliable and did not require an extra purification step 




Figure 1: DNA functionalization strategies. 
 
Based on these results, we designed and synthesized two sets of oligonucleotide probes of 
respectively 11- and 15- mer strands. Each set featured three probes, two single alkyne 
functionalized side probes and one double azide middle probe as well as a complementary 
oligonucleotide template. Both sets of probes were hybridized on their respective template and 
conjugated to each other by CuAAC. The reactions were analysed on denaturing PAGE and 
showed the successful formation of the double conjugated product between the three probes 









Figure 2: Schematic presentation of the click-chemistry based proximity ligation assay workflow. 
 
Epigenetics could be defined in simple words as the regulations of the gene expression which 
do not involve changes of the DNA sequence.[6] Different mechanisms co-exist in order to 
control the gene activities across several layers of regulatory information. At the DNA level, 
the canonical base cytosine undergoes a chemical reaction in which a methyl group is added 
on the position C(5). The 5-methylcytosine modification is an epigenetic mark and its presence 
onto a gene promoter results in the repression of the gene transcription.[7] The discovery during 
the last years of oxidized derivatives of 5-methylcytosine suggests that the DNA demethylation 
occurs through a cascade of oxidation reactions at the C(5) position. Thus, 5-methylcytosine is 
successively transformed into 5-hydroxymethylcytosine (hmC), 5-formylcytosine (fC) and 5-
carboxycytosine (caC).[8]  
 
Recently, these modifications have also been discovered in the mRNA of mammalian cells.[9, 
10, 11, 12, 13] While hypotheses are being formulated regarding their role within RNA, their exact 
functions remain elusive and are still to be elucidated. In order to study the structural and 
functional roles of hmC, fC and caC in the context of RNA, it is essential to access synthetic 
RNA material containing one or several of these bases at defined positions.  
 
Within the frame of this PhD thesis and as a team-work from the Carell Group, we aimed at 
developing synthesis towards new RNA phosphoramidite building block the three modified 






standard automated solid phase synthesis conditions so that they could be routinely used in 
RNA synthesis. 
 
The present thesis focused on the development of the caC building block. The first step was to 
design a suitable protecting group strategy. Indeed, the corresponding phosphoramidite needed 
protecting groups able to resist the solid phase synthesis conditions while being easily removed 
after the synthesis and without arming the newly generated synthetic RNA strand. As RNA is 
inherently less stable than DNA, notably towards hydrolysis, it required the use of protecting 
groups cleavable in mild conditions. Once the design established, we envisioned and performed 
the synthesis of the caC RNA building block. The new phosphoramidite was successfully 
incorporated by automated solid phase synthesis and subsequent deprotection steps allowed the 
synthesis of two RNA strands of different length, respectively 13-mer and 21-mer, containing 
the caC-modified base at a defined site. In a similar workflow, new RNA phosphoramidite of 
the modified bases hmC and fC were developed in parallel. In order to prove that the three 
modified-cytosine RNA phosphoramidites are compatible with regular canonical bases 
phosphoramidites as well as with each other, we ultimately synthesised a RNA strand 
containing all the three modified bases.       
 
Figure 3: Depiction of the phosphoramidite building blocks developed for the synthesis of RNA containing the 







1.1 DNA functionalisation by click chemistry 
1.1.1 DNA 
DNA is crucial to every living organism for the storage and the transmission of the genetic 
information from one generation to the next.[14] Like other biomolecules, DNA is a polymer 
made of the repetition of similar monomer building blocks. In the case of DNA, there are four 
monomer units so-called nucleotides. These are composed of a deoxyribose sugar unit, a 
nitrogenous base (adenine (A), cytosine (C), guanine (G) or thymine (T)) and a phosphate 
group. In the DNA polymer, the nucleotides are linked to each other via phosphodiester bonds 
at the 5’- and 3’- hydroxyl group of the deoxyribose. The nucleotide sequence defines the 
genetic information. DNA is therefore well representative of the biochemical principle stating 
the close relation between molecular structure and function of the biomolecules.[14] 
In 1869, DNA was isolated for the first time from white blood cells by Friedrich Miescher.[15] 
As he isolated it from the nuclei of the cell, Miescher named the novel substance nuclein. This 
name remains in today’s designation deoxyribonucleic acid.  The components of DNA, as well 
as the nature of the phosphate-sugar bond linking them together, were identified by Phoebus 
Levene in 1919.[16] It is only in 1944 that the role of carrier of the genetic information was 
assigned to DNA by Avery et al.[17] After isolating and purifying DNA from a strain of 
pneumococcus, they transferred it to a different strain of bacteria, which was transformed. 
Thus, they showed that DNA was responsible for the transmission of the genetic information 
and not proteins as believed until then. James Watson and Francis Crick eventually deduced 
the structure of DNA in 1953 from X-ray diffraction data obtained by Rosalind Franklin.[18, 19, 
20] The structure is an antiparallel double helix composed of two strands. Although several 
conformations of the double helix exist, genomic DNA is mostly found in the right-handed B-
form.[21] In this conformation, the helix makes a full turn every ten bases. The sugar-phosphate 
backbone of the DNA polymer is facing outside while the nitrogenous bases are in the inside 
of the double helix. The two strands are held together by hydrogen bonds between the bases of 
the opposite strands. A forms a specific base pair with opposite in the double helix T by two 






specific base pairing is responsible for the conservation of the genetic information.[20] Indeed, 
the sequence of bases in one strand determines the sequence of the other strand. Therefore, 
when the double helix is split into two strands, each strand can act as a template for the 
formation of its complementary strand thus allowing the replication of the parent double helix 




Figure 1.1: Three-dimensional structure of the DNA double helix and representation of the four nucleotide 
chemical structures, phosphate-sugar bond and selective base pairs between A:T and C:G (hydrogen bonds 
represented as dotted line). 
 
The genetic information carried by a DNA molecule is encoded by the nucleotide sequence. In 
order to generate this information, the DNA serves as the template for the formation of a 
messenger RNA (mRNA) during the so-called transcription process. This mRNA is an 
intermediate of the protein synthesis and is further translated into a sequence of amino acids. 
The relationship between the sequence of bases of the mRNA and the sequence of amino acids 
is defined by the genetic code.[23, 24] It consists of three bases, called a codon, specifying one 






1.1.2 Cu(I)-catalysed azide-alkyne cycloaddition  
The Cu(I)-catalysed azide-alkyne cycloaddition, abbreviated CuAAC, is a 1,3-dipolar 
cycloaddition reaction resulting in the formation of a 1,2,3-triazole. The CuAAC reaction is 
considered to be a catalysed version of the thermally induced reaction originally described at 
the end of the 19th century by Michael.[25]  As its mechanism and synthetic applications were 
extensively studied by Huigsen in the 1960s, it became known as the Huigsen cycloaddition.[26, 
27] In 2001, the use of Cu(I) to catalyse the reaction was reported for the first time by Tornøe 
and Meldal in the context of solid-phase peptide synthesis.[28] One year later, the reaction 
gained significant attention when two independent publications by Meldal and Sharpless 
described the dramatic acceleration on the reaction rate provided by the Cu(I) catalysis.[29, 30] 
Additionally, the catalysed cycloaddition selectively produced the 1,4-disubstituted triazole as 
the only regioisomer whereas the original reaction provided a mixture of 1,4- 1 and 1,5-




Scheme 1.1: Schematic representation of the Huigsen cycloaddition and the CuAAC. 
 
The reaction in the absence of catalyst has a very high activation barrier (~25 kcal/mol for 
propyne with methyl azide) and consequently requires high temperatures and long reaction 
times in order to proceed.[31] The addition of Cu(I) catalyst results in an alternative mechanism 
during which the reaction proceeds in a stepwise manner via a pathway with notably lower 






The mechanism of the CuAAC reaction has been the subject of much debate and studied since 
the first mononuclear model proposed by Fokin, Sharpless and co-workers.[30, 31, 32, 33, 34, 35] The 
commonly accepted current model relies on the formation of dinuclear copper intermediates. 
Indeed, in 2013 Fokin demonstrated by real-time monitoring of the reaction that dinuclear 
copper intermediates are involved.[33] Based on these results, Fokin proposed the following 
mechanism (Scheme 1.2).  The first step consists in the formation of a Cu(I)-alkyne π-complex 
3. The addition of a second copper gives a σ, π-di(copper) acetylide intermediate 4 which 
allows the coordination of the azide 5 via the internal nitrogen to the σ-coordinated copper. 
The complex 6 thus formed undergoes a stepwise cycloaddition. At first, a metalocyclic 
intermediate 7 containing an endo- and an exocyclic copper center is formed via C-N bond 
formation. Elimination of the endocyclic copper forms the triazolide intermediate 8. The 
protonation of the latter regenerates the copper catalyst and free the triazole 9. 
  
 
Scheme 1.2: Proposed mechanism of the CuAAC reaction according to Fokin et al.[33] R1 and R2 = any residue 
except H. 
 
Since its discovery, the CuAAC reaction is considered the prototypical example of the term 
“click chemistry”. Sharpless formulated this term in 2001 and defined a click chemistry 
reaction as a reaction with some of the following features:[36] modularity, wide in scope, very 






Indeed, in addition to its intrinsic impressive reaction rate and regioselectivity, the CuAAC 
reaction also has the benefits of being very reliable and versatile while the 1, 2, 3-triazole 
product is a very stable adduct. Thanks to these attributes, the CuAAC reaction has been used 
in a wide range of applications, from drug discovery[37] to supramolecular chemistry.[38] One 
speciality area of chemistry where employing the CuAAC reaction was demonstrated to be 
particularly advantageous is for the conjugation of biomolecules.[39] Indeed, neither alkynes 
nor azides functionalities naturally exist in vivo while both are stable under physiological 
conditions and inert towards the native chemical functionalities. The CuAAC is, therefore, a 
bioorthogonal reaction and remains to date one of the most powerful bioconjugation tools. 
 
 
Figure 1.2: Illustration of the bioorthogonality of the CuAAC reaction. 
 
The main limitation of the CuAAC as a bioorthogonal reaction in living systems lies in its 
reliance on copper catalysis since Cu(I) is potentially toxic in living systems.[40, 41] Cu(I) is 
unstable under physiological conditions and is oxidized into Cu(II) by O2 or H2O2 via the 
Fenton reaction (Figure 1.3A). This process promotes, in turn, the production of the ROS 
superoxide and hydroxyl radicals known to cause oxidative stress to the cells and damage the 
biomolecules.[42]  
Several strategies have been developed in order to decrease the cellular toxicity associated to 
the Cu(I) catalyst. One of them consists in the incorporation of copper-binding ligands to the 
reaction.[43, 44] Such ligands will increase the acceleration rate of the reaction by stabilizing the 
copper catalyst in its active oxidative state while decreasing the risk of causing oxidative stress. 






used ones are the ligands from the tris((triazolyl)methyl) amine class: TBTA 10[43], THPTA 
11[44], BTTAA 12[45] and TABTA 13[46] (Figure 1.3B).  
A second strategy for decreasing the toxic effect of the Cu(I) is to use copper-chelating 
azides.[4] Such chelating groups bind the copper directly at the reaction center and are reported 
to significantly increase the reaction rate while using lower catalyst concentrations without 
compromising the CuAAC efficiency. For example, in a comparative study with the 
corresponding non-chelating azide, the picolyl azide group (Figure 1.3C), in combination with 
BTTAA, provided a 25-fold enhancement in labelling proteins.[47]  
 
 
Figure 1.3: A) Cu(I)-promoted generation of ROS; B) Tris((triazolyl)methyl) amine ligands used in the CuAAC 












1.1.3 CuAAC reaction on nucleic acids 
Thanks to its fast reaction kinetics and bioorthogonality, the CuAAC found a significant 
number of applications in the context of DNA and RNA modifications. Examples of such 
applications range from the labelling of oligonucleotides with various fluorescent reporters [48, 
49, 50], ligation of several DNA strands[51, 52] or surface functionalization in microarrays [53].  
 
The three components of the nucleotide unit, the (deoxy)ribose sugar unit[54], the nucleobase 
and the phosphate group[55], have been subjected to chemical modifications towards the 
introduction of click reactive functions. However, the most common type of modifications 
towards the generation of clickable nucleotide analogues are located on the nitrogenous base 
moiety[3]. 
 
The development of such modified nucleosides as well as the methodologies to efficiently label 
DNA by click chemistry were initiated by the Carell Group. Alkyne nucleosides analogues 
have been introduced by both automated solid phase synthesis and enzymatic reaction. For the 
first approach, the synthesis of an alkyne-uridine phosphoramidite enabled the site-specific 
introduction of alkynes functions inside oligonucleotides[56]. These modifications proved to be 
compatible with the reaction conditions of solid phase synthesis and the obtained 
oligonucleotides could be post-synthetically labelled with a high efficiency. In parallel, the 
corresponding alkyne triphosphates were also synthesized and used in polymerase chain 
reactions.[57] Not only the modified triphosphates 14 were accepted as substrate for the 
enzymatic reactions, but also the subsequent click reaction on the PCR product permitted a 
high-density functionalization while no DNA damages were detected. Indeed, RT-PCR 
analysis shown that the 887 cytidines of a 2000 base pairs DNA strand had been replaced by 
their alkyne-modified analogue. Following click reaction with a sugar azide 15, the DNA 
products were digested and analysed by HPLC revealing an impressive and almost quantitative 








Figure 1.4: PCR in the presence of deoxyadenosine triphosphate (dATP), deoxycytidine triphosphate (dCTP), 
deoxyguanosine triphosphate (dGTP) and a uridine alkyne triphosphate analogue 14 (d*UTP) and subsequent 






1.2 Bioassays based on nucleic acid amplification 
DNA and RNA amplification methods represent a great tool for the detection of defined nucleic 
acid sequences. Indeed, they provide an excellent specificity thanks to the strong affinity 
between two complementary oligonucleotide strands. Moreover, the intrinsic exponential 
amplification enables the generation of a large number of identical copies of a target sequence 
and therefore a potentially very high detection sensitivity.  This is particularly important when 
very small amount of material available to analyse. This can be the case in clinical diagnostics 
where human samples are being analysed and nucleic acid amplification represents thus a 
valuable detection method in many areas. 
 
1.2.1 Real-time Polymerase Chain Reaction 
Several strategies have been described towards the amplification of DNA or RNA such as 
polymerase chain reaction (PCR)[58, 59], strand displacement amplification[60] or self-sustaining 
sequence amplification[61]. PCR was the first of these methods to be developed in the 1980s by 
Kary Mullis and remains to date the most commonly used one. A PCR assay is performed 
according to the following steps: first, the reaction solution is heated above the melting point 
of the complementary DNA strands of the target to be amplified and detected. Once the strands 
are separated during this so-called denaturing step, the temperature is decreased to allow the 
primers to bind specifically to the target sequence. This is the annealing step, which is followed 
by a new increase of temperature enabling the DNA polymerase to extend the primers by 
adding the nucleoside triphosphates to the developing DNA strand complementary to the target 
sequence. This completes once cycle of PCR, which is repeated numerous times. At the end of 
each step, the number of identical copies of the target sequence is doubled and within a few 
hours, millions of copies are generated. 
 
Table 1.1: Reagents and equipment required for a PCR assay. 
Reagents and equipment Description 
Target sequence (or template) Segment of nucleic acid to be amplified 
Deoxynucleoside triphosphates 







Table 1.1: Continued. 
 
The first PCR application was reported in 1985  and performed for the diagnosis of the genetic 
disorder sickle cell anemia.[63] The DNA polymerase used was an enzyme isolated from E. coli, 
Klenow fragment DNA polymerase I. However, this enzyme was destroyed at the temperature 
of the denaturing step and it was necessary to add fresh enzyme for each cycle. An important 
development for the PCR assays was the introduction of a thermostable DNA polymerase from 
the bacteria Thermus aquaticus (Taq).[64, 65] The latter belongs to a species of bacteria tolerating 
high temperatures and its enzymes can survive and sustain their activities accordingly. The Taq 
DNA polymerase can survive the incubation temperature of the denaturing step and it is mostly 
active at 70 °C. Thus, it circumvented the necessity of adding fresh enzyme at each PCR cycle 
making the whole assay easier to perform and more rapid and efficient. 
 
A second important advancement for PCR assays was the demonstration of real-time PCR by 
Higuchi et al. at Roche Molecular Systems at the beginning of the 1990s.[66, 67] Indeed, PCR 
products were formerly detected and visualized by agarose gel electrophoresis. The 
introduction of real-time PCR permitted the coupling of the tremendous intrinsic sensitivity of 
PCR to the precision gained from real-time monitoring and detection of amplification products 
as they are generated. The initial real-time PCR described relied on the double-stranded DNA 
intercalating fluorescent dye ethidium bromide and the reaction was run under UV light. As 
the ethidium bromide was intercalated in the increasing amount of DNA produced at each 
cycle, it induced an increase of fluorescence upon irradiation of the UV light inside the 
thermocycler. Moreover, by measuring the increase of fluorescence after each cycle, it also 
allowed the accurate calculation of the initial amount of target DNA. In this regard, the terms 
real-time and quantitative PCR are often used in combination or as interchangeable. The first 
commercial instrument was made available on the market in 1996 by Applied Biosystems and 
it was followed by numerous other companies.[68] The influence of the assay is also reflected 
Primer 
Short DNA strand complementary to a 
sequence of the target to be amplified 
DNA polymerase 
Enzyme synthesizing new complementary 
copies of the target sequence  
Thermocycler 
Equipment in which the PCR assay is 
performed. Able to raise and lower the 







in the number of scientific publications citing real-time quantitative PCR as their number went 
through an exponential growth over about 10 years following its commercialization.[69] 
Since its first iteration by Higuchi et al., many methods for the detection of the PCR product 
have been described. They can be divided into two categories depending on whether they detect 
only specific or both specific and non-specific amplification products. For the latter category, 
double-stranded DNA intercalating agents such as the previously-mentioned ethidium 
bromide,[66, 67] SYBRGreen,[70] or EvaGreen are used.[71] Specific probes, however, are based 
on oligonucleotides linked with a fluorescent reporter. Here as well, the specificity of such 
probes lies in the complementarity between the probe strand and a sequence of the DNA target. 
These probes can induce the emission of fluorescence upon hybridization by diverse 
mechanism of actions. The different types of probes thus existing can be distinguished as 
following: primer-probes acting as a primer with the target sequence; hybridization probes 
emitting fluorescence upon hybridization on the target sequence; hydrolysis probes emitting 
fluorescence upon degradation of the probe after hybridization to the target sequence; 
analogues of nucleic acids with mechanisms of action similar to the previous probes but whose 
structure is not a conventional oligonucleotide. The table 1.2 provides examples of the different 
types of specific probes.  
 
Table 1.2: Real-time PCR specific probes. 
Primer probe – Scorpions[72] 
 
Structure  Mechanism of action  
Hairpin structure with a reporter at the 5′-end and a 
quencher at the 3′-end of the hairpin. The latter is 
attached to the 5′-end of the primer by a short PEG 
blocker blocking its extension by the polymerase. 
When in solution, the reporter fluorescence is 
quenched by the proximity with the quencher by 
FRET-quenching. Once the primer-probe is 
hybridized on the target DNA, the polymerase 
amplifies the sequence from the 3′-end of the primer. 
During the denaturation step, the specific sequence 
of the probe binds to the complementary region 
within the same strand of newly amplified DNA. 
This hybridisation event opens the hairpin loop so 






Table 1.2: Continued. 
Hybridization probe – Molecular Beacon probe[73] 
 
Structure Mechanism of action 
Hairpin structure with a reporter at the 5′-end and a 
quencher at the 3′-end of the hairpin. 
During the annealing phase, this probe unfolds and 
binds to the target, emitting fluorescence since the 
reporter is not quenched any longer. If the Molecular 
Beacon probe and target DNA sequences are not 
perfectly complementary, there will be no emission of 
fluorescence as the hairpin structure prevails over the 
hybridization. 
Hydrolysis probe – TaqMan[74] 
 
Structure Mechanism of action 
Oligonucleotide with a fluorescent reporter at the 5′-
end and a quencher at its 3′-end. 
When in solution, the reporter fluorescence is 
quenched by the proximity with the quencher by 
FRET-quenching. During the amplification phase, the 
probe is hydrolysed by the exonuclease activity of the 
DNA polymerase. This leads to the departure of the 
reporter, which is no longer in proximity of the 











Table 1.2: Continued. 
Analogues of nucleic acids – PNAs[75] and LNAs[76] 
 
Structure Mechanism of action 
PNAs or LNAs probes. The mechanisms of action of PNAs and LNAs probes 
are similar to the conventional oligonucleotide ones. 
 
Thanks to its impressive sensitivity and ease of use, real-time quantitative PCR has been widely 
employed in many different fields of application. It has for example been used in biomedical 
research for the genotyping of mutations and in particular for single nucleotide polymorphisms 
by automatically performing a melting curve analysis after completion of the PCR.[77] As a 
molecular diagnostic tool, it proves its usefulness for the detection of bacterial and viral genetic 
material.[78] Indeed, it offered the possibility to detect pathogen-specific sequences within 
complex sample mixture. Another field where the capability to detect low amount of a specific 
gene sequence represents an important potential is in clinical oncology.[79] Real-time PCR 
intrinsic sensitivity and precision not only allowed better detection of disease but also provided 
















1.2.2 Proximity Ligation Assay 
One successful method based on nucleic acid amplification and developed for in vitro detection 
and visualisation of proteins is the proximity ligation assay (PLA). PLA was first demonstrated 
in 2002 by Landegren et al.[1] While the method has been developed since its introduction and 
several variations have been described, the basic principle remains unchanged.[80] The PLA 
relies on a pair of affinity probes for a protein target. The latter can be either a single protein 
or a protein complex.[81] In the first demonstration of the assay, the proximity probes used were 
a pair of DNA aptamers with extended sequences required for the proximity ligation reactions.  
Alternatively, an assay based on antibodies as affinity probes has also been developed.[82] In 
this case, the antibodies are attached to DNA strands. Once the two probes are close to each 
other by binding the same target, an oligonucleotide is hybridized on both probes at the same 
time. The two probes will then serve as a guide to promote the formation of circular structure 
from the linear oligonucleotide by joining its two extremities in an enzymatic reaction. 
Subsequently, one of the DNA strand probes acts as a primer in a rolling circular amplification 
(RCA) where the previously ligated oligonucleotide is used as a circular template. RCA is an 
alternative amplification method to PCR, which on the contrary is an isothermal process and 
does not require a thermocycler. In RCA, the polymerase continuously extends the primer due 
to the circularity of the template. Therefore, the amplification product is a long DNA single 
strand remaining attached to the primer and with thousands of successive repetitions of the 
complementary sequence of the circular template.[83] The amplification product can be detected 
by fluorescence in situ hybridization (FISH) with complementary oligonucleotide probes and 
its signal can be easily observed with a microscope. Thanks to the extremely low amount of 
proteins that the assay is able to detect, the PLA became a valuable technology for a large 









Figure 1.5: Depiction of a Proximity Ligation Assay (PLA). If two proximity probes are close to each other (pink 
and light blue), by binding a two-protein complex (yellow and green), then subsequently added template (orange) 
can be hybridized to the proximity probes and transformed into a circular structure by enzymatic DNA ligation. 
Rolling circular amplification (RCA) is then initiated and the amplification product is detected by FISH probes 
(pink).





2. DEVELOPMENT OF A CLICK CHEMISTRY-BASED PROXIMITY 
LIGATION ASSAY   
2.1 Objectives 
One of the goal of the present thesis was to investigate if the Cu(I)-catalyzed azide-alkyne 
cycloadditon (CuAAC) could be used in the context of a proximity ligation assay in order to 
push further the potential of this method. Thanks to its efficiency and its bioorthogonality, we 
believed that the so-called click reaction can contribute to the development of a more precise 
and sensitive PLA. Towards this purpose, we developed the following design as a proof of 
concept: Three oligonucleotide probes, functionalized with alkyne or azide functions, can 
hybridize with a single non-modified oligonucleotide template. Thanks to the proximity 
brought by the hybridization on the template, the three probes are then further conjugated to 
each other by click chemistry providing a single covalently bound product. The template aims 
therefore in this design at mimicking the proximity of the PLA to react probes when placed 
close to each other. This design also makes use of three probes instead of two in the PLA, 
adding thus one degree of precision. We therefore named this assay proof of concept click 
Proximity Ligation Assay (CLICKPLA). Two versions of this design have been envisioned 
(Figure 2.1).  
One, where the middle probe bears two alkyne functions and the side probes one azide function 
each. A second one where the middle probe is functionalized with two azide functions and the 
side ones with one alkyne function each. This project involved therefore the development of 
the corresponding oligonucleotide functionalization chemistry as well as the synthesis of the 
linkers required. 
 







Figure 2.1: Schematic representation of the two CLICKPLA versions. The oligonucleotide probes are represented 
in green. The oligonucleotide templates are in purple. At first, three probes are hybridized to the complementary 
template. In a second time, the click reaction can be initiated and the three probes are conjugated to each other.   





2.2 Synthesis of azide functionalized ODN 
2.2.1 Strategy 
The first part of this project was to develop a functional and reliable strategy towards the 
synthesis of DNA strands modified with one or two azide functions. Even if a few examples of 
direct incorporation of azide functions during DNA solid phase synthesis have been reported 
[85, 86], they are usually not compatible with with P(III) as they are prone to Staudinger-type 
side reactions.[87, 88]. However, for DNA strands, a post oligo synthesis functionalization step 
is usually performed to introduce azide functionalities and the most common approach consists 
in reacting an activated ester with an amino modified oligonucleotide.[89] Using this strategy, 
bifunctional NHS-azide linkers have been reacted with oligonucleotides carrying a modified 
amine nucleoside or with a 5’ or 3’ amino modifier.[51, 90] However, this method is not 
chemoselective and lacks in efficiency as NHS esters can react with other nucleophiles present 
on DNA. Contrary to azide moieties, alkyne ones are easily introduced during solid phase 
synthesis of oligonucleotides enabling post-synthetic labelling of the modified strands with 
various azide reporters by CuAAC.[48, 91] Thus, an alternative method to generate a DNA strand 
with an azide moiety is to click a symmetrical bis-azide linker on an oligonucleotide with an 
alkyne modified nucleobase.[92] Here again, the level of selectivity of this method is relative as 
the second azide group of the linker might react with another strand yet unreacted thus leading 
to a cross-linked side product.[93, 94] In 2009, Zhu et al. discovered that chelating azides can 
react in CuAAC reactions with only a small amount of copper (II) acetate (down to 1 mol %) 
and in the absence of a reducing agent such as sodium ascorbate.[4] This superior reactivity in 
comparison with non-chelating azide is explained by the chelation of the copper catalyst 
directly to the catalytic center of the reaction. After testing several auxiliary ligands near the 
azido group, they reported the pyridyl group as the best capable copper chelating group.[95] The 
reactivity difference between chelating and non-chelating azide is such that under specific 
conditions (copper (II) acetate as catalyst, no reducing agent), when both a chelating and a non-
chelating azide are present, only the so-called picolyl azide is going to react with an alkyne. 
Based on these results, they designed unsymmetrical bis-azide (one chelating, one non-
chelating) linkers and proved that both azido groups can be reacted in a sequential and 
chemoselective procedure with two distinct alkynes.[5] Seela et al. successfully applied this 
method on alkyne nucleosides and oligonucleotides with 2,5-bis(azidomethyl)pyridine as 





unsymmetrical bis-azide linker.[96] We decided to adopt a similar approach tailored for the 
CLICKPLA. In our proof of concept design, the alkyne and azide functionalities to be conjugated 
with each other needs to be carried at the end of long and flexible linkers. Indeed, these 
chemical groups will each be incorporated in different strands and thus, short linkers would not 
allow the click reactions to take place as the CuAAC reactive group could not be nearby each 
other. Consequently, as a backbone for the linkers to synthesize, we used poly(ethylene-glycol) 
(PEG) chains. These polymers, contrary to alkyl chains, have the advantages to be non-rigid 
and water-soluble.[97] Also, they are commercially available in a wide range of lengths allowing 
us, had it been necessary, to modulate the length of the linkers. As the alkyne component to be 
incorporated within the oligonucleotides during the solid-phase synthesis, we chose the C8-
alkyne-dU nucleoside developed in our group.[91] Eventually, our strategy towards the 
synthesis of azide functional DNA strands consisted in: 
1- Synthesis of oligodeoxyribonucleotides containing one alkyne group; 
2- Synthesis of unsymmetrical picolyl azide/azide long and water-soluble linkers; 
3- Chemoselective CuAAC conjugation between the alkyne DNA strand and the chelating 
azido group of the unsymmetrical bis-azide linker leaving the non-chelating azide free and 




Figure 2.2: Chemoselective strategy towards the synthesis of azido functional DNA strands. The chelating azido 
group of an unsymmetrical bis-azide linker is conjugated by CuAAC to an oligodeoxynucleotide containing a C8-
alkyne-dU artificial nucleoside in a chemoselective procedure.  





2.2.2 Synthesis of unsymmetrical picolyl azide/azide linkers 
The initial step in order to synthesize unsymmetrical picolyl azide/azide linkers was to obtain 
a picolyl azide building block able to be further conjugated in a compatible and orthogonal 
reaction with the azide function. We followed the published procedure from Uttamapinant et 
al. with minor adjustments giving access to a carboxylic acid picolyl azid (6-
azidomethylnicotinic acid) 16.[47] The carboxylic acid, upon activation, was further reacted 
with the amino group of different molecules via amid coupling. In order to generate an amine 
reactive ester from the carboxylic acid we used  HATU as a reagent along with Hünig’s base, 
this coupling being known to provide high coupling efficiencies and fast rates.[98]  The first 
unsymmetrical picolyl azide-PEG10-azide linker 17 was readily available in one step from 
coupling the carboxylic acid picolyl azid to a commercial azido-PEG-amine reactant. We chose 
as starting material an azido-PEG-amine with 10 poly(ethylene oxide) monomer units 18 as we 




Scheme 2.1: Synthesis of the unsymmetrical picolyl azide-PEG10-azide linker 17. 
 
In order to prepare a second linker bearing one picolyl azide and two non-chelating azido 
groups 19, we imagined a synthesis based on methyl 3,5-dihydroxybenzoate 20 (Scheme 2.2). 
This starting building block offers the advantage of having two identical chemical groups (two 
hydroxyl groups) as well as a third protected one (carboxylic acid protected as methyl ester) 
and thus can be used as a bifunctional core.[99] Therefore, the two hydroxyl groups eventually 
bear the two azido groups of the final linker whereas the carboxylic acid was coupled to a 
picolyl azide/amine linker 21. 
 







Scheme 2.2: Retrosynthetic analysis of picolyl azide/bis-azide linker 19.  
 
 
In order to functionalize the two hydroxyl groups we synthesized a linker based on 
tetraethylene glycol 22 and bearing on its two respective free alcohol moieties an azido group 
and a tosylate group 23 (Scheme 2.3). The first hydroxyl group was selectively tosylated by 
using tosyl chloride. In order to minimize the formation of the double tosylated unwanted 
product, the tosyl chloride was firstly dissolved in tetrahydrofuran and this solution was 
subsequently added very carefully (drip in over one hour) to a solution of tetraethylene glycol 
at 0 °C. The two reactants were finally in stoichiometric rate and the mono tosylated product 





was obtained in a satisfying 72 % yield. In the next step the tosylate group was substituted by 
an azido group by stirring the compound with sodium azide salt. Lastly, the second alcohol of 
the tretraethylene glycol was tosylated as well. 
 
 
Scheme 2.3: Synthesis of the Azido-PEG3-OTs linker 23.  
 
The carboxylic acid picolyl azide building block 16 was coupled here again using HATU to N-
Boc- 2,2′-(ethylenedioxy)diethylamine 27 (Scheme 2.4). The Boc protecting group on the 
second amine was removed by a treatment with 2 M HCl to provide the short linker 
picolylazide-PEG2-amine 21. 
 
Scheme 2.4: Synthesis of Picolyl azide-PEG2-amine 21. 
 
The first step towards the synthesis of the picolyl azide/bis-azide linker from methyl 3,5-
dihydroxybenzoate was the conjugation on the hydroxyl groups of the azido-PEG3-OTs linker 
24. This was achieved by deprotonating the two hydroxyl groups which could thus substitute 
each the tosylate of one azido-PEG3-OTs linker 23. Potassium carbonate was used as a base 
instead of sodium or lithium hydroxide to prevent the hydrolysis of the methyl ester. This 
double conjugation was performed with a yield of 77 %. The carboxylic acid on the core was 
subsequently deprotected by saponification with sodium hydroxide. Finally, the carboxylic 





acid was activated by HATU and was further coupled to the picolylazide-PEG2-amine linker 
to provide the Picolyl azide/bis-azide linker 19. 
 
 
Scheme 2.5: Synthesis of the picolyl azide/bis-azide linker 19. 





2.2.3 Click experiments 
The ability of the picolyl azide-PEG10-azide linker 17 to be clicked in a chemoselective 
protocol was assessed with a 11-mer oligodeoxyribonucleotide containing one C8-alkyne-dU 
nucleoside. Several stoichiometric ratios of copper catalyst/alkyne-carrying ODN and linkers/ 
alkyne-carrying ODN were tested in order to find the best conditions for: 
1- Performing the reaction until full completion; 
2- Achieve the highest possible chemoselectivity and prevent side reaction on the non-chelating 
azido group. 
The different conditions tested are listed in Table 2.1. The reactions were performed in parallel, 
over the same time and at the same temperature. The final concentration of the DNA strand 
was identical in each sample. 
 
Table 2.1: Click screening with the picolyl azide-PEG10-azide linker 17. [*] The percentage of 




Stoichiometric                                  
ratio                           
linker/alkyne 
Stoechiometric                                  














2 20 2 97.4 
3 50 2 98.8 
4 10 5 90.2 
5 20 5 97.0 
6 50 5 98.8 
7 10 10 87.8 
8 20 10 96.7 
9 50 10 97.6 
 
 





The HPLC chromatograms of the crude products from the samples 1, 4 and 7 show a small 
signal corresponding to the unclicked alkyne-ODN. The starting material was also detected in 
the crude product of these samples by measuring their MALDI-TOF spectra. For all the other 
samples, the completion seems to be total as no signal from the unclicked ODN was detected 
in the crude products neither by HPLC nor by MALDI-TOF (Figure 2.3). In addition, the 
approximate calculations of the percentage of completion of these reaction provided all data 
superior up to 95 %. For all the sample crude products, no other signal than the ones 
corresponding to the linker in excess and the target product were detected. Based on this 
analytics, we decided to choose the condition of the sample 2 (2 equivalents of copper catalyst; 
20 equivalents of linker) for further click reactions of the picolyl azide-PEG10-azide linker 17 
on alkyne ODN. Indeed, these conditions provided a full completion while requiring the 
smallest amounts of catalyst and reactant. 
 
 
Figure 2.3: (A) HPLC profile of the crude product from the sample 2 (see Tab. 2.1). The starting materials, 
alkyne-carrying ODN (green dotted) and the picolyl azide-PEG10-azide linker 17 (blue dotted) are depicted for 
comparison. (B) HPLC profile of the purified product from sample 2 and the corresponding MALDI-TOF 
spectrum (inset). 
 
We performed a similar click screen with the picolyl azide/bis-azide linker 19. We chose again 
an 11-mer oligodeoxyribonucleotide containing one C8-alkyne-dU nucleoside (Table 2.2). The 
different stoichiometric ratios of copper catalyst/alkyne-carrying ODN and linkers/ alkyne-
carrying ODN tested are shown in the Table 2.2. Based on the results from the screening with 
the picolyl azide-PEG10-azide linker 17, we narrowed down the number of conditions to test 
A                                                         B 





this time. Indeed, it did not seem necessary to investigate higher excess of respectively 5 for 
the copper catalyst and 20 for the linker. 
 
Table 2.2: Click screening with the picolyl azide/bis-azide linker 19. [*] The percentage of completion of the 




Stoichiometric                                  
ratio                           
linker/alkyne 
Stoechiometric                                  














2 20 2 >99.9 
3 10 5 99.3 




The HPLC chromatograms of the crude product of every sample show a full conversion as well 
as the crude MALDI-TOF spectra where no unclicked ODN was detected. This was verified 
after integrating the area of the chromatograms corresponding to the starting ODN and the 
target clicked product. However, for every condition tested, an additional signal appearing 
shortly before the elution of the target product was detected. The ratio of the trace of this side 
product to the trace of the target product was about 25/75 and constant for every sample. No 
additional signal were detected in the MALDI-TOF spectra of the crude products. After 
isolating this HPLC trace from the crude product by preparative HPLC and measuring its 
MALDI-TOF spectrum we found that it had the same mass of the target product. Therefore, 
we hypothesized that on some ODN, one of non-chelating the azido-group of the linker reacted 
instead of the picolyl azide giving as a result the same mass as the target clicked product. 





Nevertheless, since this side reaction never accounted for more than a fourth of the target 
product and did not prevent the isolation of this last species in sufficient amount for the next 




Figure 2.4: (A) HPLC profile of the crude product from the sample 1 (see Tab. 2.2). The starting materials, 
alkyne-carrying ODN (pink dotted) and the picolyl azide/bis-azide linker 19 (red dotted) are depicted for 
comparison. (B) HPLC profile of the purified product from sample 1 and the corresponding MALDI-TOF 
spectrum (inset).
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2.3 Synthesis of alkyne functionalized ODN 
2.3.1 Strategy 
The next step of this thesis project was to develop a strategy towards the functionalization of 
DNA strands with alkyne groups at the end of long spacers, here again for the needs of the 
CLICKPLA. As well as for the synthesis of azide functionalized ODN described in the previous 
section, we decided to rely on the incorporation of the C8-alkyne-dU nucleoside by solid phase 
synthesis.[91] The alkyne group present on the C8-alkyne-dU needing to be extended. We 
envisioned a sequential strategy as described by Leigh et al. and previously applied in our group 
to successively click different labels on one single oligonucleotide.[48, 100] In this method, a first 
alkyne is clicked while a second one remains protected by a silyl group. Upon the first click, 
the second alkyne is deprotected and clicked in turn, with another azide label (Figure 2.5). 
Therefore, we decided to synthesize bifunctional linkers bearing one azide moiety as well as 
one or two alkyne ones. Once again and for the same reasons mentioned previously, 
poly(ethylene glycol) chains were chosen as the backbone structures of the linkers to be 
synthesized. Considering the very high coupling efficiency demonstrated in the previous 
section by the chelating azido group, we designed syntheses towards linkers bearing picolyl 
azides rather than non-chelating azides. 
 
Figure 2.5: Sequential strategy towards the synthesis of alkyne functional DNA strands. The chelating azido 
group of an unsymmetrical azide/protected alkyne linker is conjugated by CuAAC to an oligodeoxynucleotide 
containing a C8-alkyne-dU artificial nucleoside. The alkyne of the linker is be subsequently deprotected.





2.3.2 Synthesis of picolyl azide/alkyne-TMS linkers 
At first we considered the synthesis of a linker bearing a trimethylsilyl (TMS) protected alkyne. 
Indeed this protecting group presents the advantage that it can be removed under mild 
conditions.[48] This property of the TMS protecting group to be easily cleaved off also makes 
the synthesis of molecules attached to it challenging. Indeed, TMS are unstable towards many 
conditions.[101] Thus, once introduced during a synthesis, the protected molecule should not 
undergo any harsh synthetic step in order to keep the TMS in place. The most reliable method, 
in our opinion, is to introduce the TMS group during the last step of the synthesis of the 
molecule of interest.  
 
 
Scheme 2.6: Synthesis of 5-(Trimethylsilyl)pent-4-ynoic anhydride 28. 
 
Based on a procedure described by Boons et al., we synthesized a symmetric acid anhydride 
with two TMS protected alkynes 28 (Scheme 2.6).[102] This molecule can readily react with an 
amino group under conditions in which the TMS is stable. The next step was then the synthesis 
of a long unsymmetrical PEG linker respectively terminated on its two respective extremities 
by a picolyl azide and a free amino group 31 (Scheme 2.7).  
 
 
Scheme 2.7: Synthesis of the picolyl azide-PEG11-TMS protected alkyne linker 34. 





The synthesis of such linker was already achieved as described during the section 2.2.2 
(Scheme 2.4) with a short linker. Here we substituted the Boc-PEG2-amine 27 by a Boc-PEG11-
amine 32 and applied the same synthetic procedure (Scheme 2.7). First, the PEG linker was 
conjugated to the picolyl azide carboxylic acid reactant 16 via an amide coupling. The second 
amine of the PEG chain was then deprotected from its Boc group by acid hydrolysis. At last, 
the acid anhydride 28 was coupled to the linker 33 here again through an amide linkage 
providing the picolyl azide-PEG11-TMS protected alkyne linker 34 in an excellent yield (98 
%). 
 
2.3.3 Click experiments  
Before performing a click screen, as previously described and in order to optimize the 
couplings efficiency, we made a quick test regarding reaction between a 15-mer alkyne 
oligodeoxyribonucleotide and the picolyl azide-PEG11-TMS protected alkyne linker 34 with 
standard click conditions: 
- Copper sulfate as the source of metal catalyst; 
- Sodium ascorbate as the reducing agent; 
- BTTAA as the copper (I) stabilizing ligand.  
 
 
Figure 2.6: Analysis of the crude product from the click reaction (A) HPLC profile. The starting materials, alkyne-
carrying ODN (blue dotted) and the the picolyl azide-PEG11-TMS protected alkyne linker 34 (green dotted) are 
depicted for comparison. (B) MALDI-TOF spectrum. 
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However, to our disbelief, the analysis of the crude product by HPLC provided a profile with 
several signals (Figure 2.6). If the starting alkyne ODN seemed to be fully reacted, it appeared 
several by-products had been generated during the click reaction. Further analysis by MALDI-
TOF mass spectrometry confirmed that in addition to the target product, at least two side-
products had been formed. We hypothesized that the TMS protecting group might be removed 
during the click reaction after conjugation to the ODN. We thought that the linker being in 
excess (10 equivalents), it could happen that unreacted linkers might have clicked onto the 
already conjugated but deprotected ones. Calculations of the intrinsic molecular weights of 
such ODN with several linkers successively clicked provided indeed the values found in the 
MALDI-TOF spectrum of the crude product thus confirming this hypothesis (Table 2.3). 
 
Table 2.3: Mass spectrometric data of the click crude product with the picolyl azide-PEG11-TMS protected alkyne 
linker 34.
Sequence Calcd [M-H]- Found [M-H]- 
5' CATTAAAGGTGAA-X1-T 3' 5488.5 5482.9 
5' CATTAAAGGTGAA-X2-T 3' 6272.9 6267.3 
5' CATTAA AGGTGAA-X3-T 3' 7057.3 7051.7 
 





2.3.4 Synthesis of picolyl azide/alkyne-TES linkers 
Since the TMS alkyne protecting group was not stable enough for our purposes, we decided to 
replace it by a triethylsilyl (TES) protecting group which is notably less labile than TMS and 
can be cleaved off by fluoride ions from water soluble salts such as potassium fluoride or 
sodium fluoride.[103] We developed a synthesis similar to the one which provided the picolyl 
azide-PEG11-TMS protected alkyne linker 34. Starting from the readily protected 5-
triethylsilyl-4-pentyn-1-ol 35, we oxidized it into a carboxylic acid 36 with pyridinium 
dichromate. Since TES is not as sensitive as TMS, we conjugated directly the TES carboxylic 
acid 36 to the picolyl azide-PEG11-amine linker 33 in a one-pot HATU mediated coupling to 




Scheme 2.8: Synthesis of the picolyl azide-PEG11-TES protected alkyne linker 37. 
 
In parallel to the synthesis of the mono-TES protected alkyne linker, we undertook the 
challenge of designing and achieving the synthesis of an unsymmetrical linker bearing one 
picolyl azide and two TES protected alkyne. A similar approach as the one that allowed the 
synthesis of the picolyl azide/bis-azide linker 19 and based on the starting building block 
methyl 3,5-dihydroxybenzoate 20 was adopted. The first step was the conjugation of the two 
hydroxyl groups present on the starting core with a PEG linker bearing a Boc-protected amino 
group 38.  To this aim, the azide of the azido-PEG3-OTs linker 23 was reduced into an amine 
by catalytic hydrogenation with palladium on carbon, which was directly reacted with Boc 
anhydride in a one pot procedure (Scheme 2.9). 
 






Scheme 2.9: Synthesis of the Boc-PEG3-OTs 38. 
 
The two hydroxyl groups of methyl 3,5-dihydroxybenzoate 20 were deprotonated with 
potassium carbonate in order to substitute the tosyl group of the linkers 38 (Scheme 2.10). The 
double conjugated product was obtained with a 70 % yield. The methyl ester on the core was 
hydrolysed with sodium hydroxide. This deprotection proceeded orthogonally and the two Boc 
protecting groups remained on the molecule 39. Once free, the carboxylic acid of the core was 
activated by the tandem HATU/DIPEA and coupled to the picolylazide-PEG2-amine linker 21. 
Eventually, the two Boc protecting group were removed by a hydrochloric acid solution in 
dioxane and the two amino groups were reacted in an amide coupling to the TES carboxylic 
acid 36. The picolyl azide/bis-TES protected alkyne linker 40 was provided in a quasi-
quantitative yield. 
 







Scheme 2.10: Synthesis of the picolyl azide/bis-TES protected alkyne linker 40.





2.3.5 Click experiments and deprotection 
We first tried to click the picolyl azide-PEG11-TES protected alkyne linker 37 onto a 11-mer 
ODN containing one C8-alkyne-dU modified nucleoside. As for the TMS linker 34, we used 
standard click reagents (copper sulfate as source of metal catalyst; sodium ascorbate as 
reducing agent; BTTAA as a copper (I) stabilizing ligand). In order to optimize the reaction, 
we tested several stoichiometric ratios of copper (2, 5 and 10 equivalents) and linker (5, 10 and 
20 equivalents) to the alkyne-bearing ODN (Table 2.4). This optimization was done in order 
to perform the reaction with the highest conversion possible while using the minimal amount 
of reactant and catalyst. This is particularly important regarding the copper reagent in order to 
prevent metal induced catalytic cleavage of the DNA strand.[104] Every reaction was performed 
in parallel, for the same time duration and at the same temperature. The final concentration of 
the DNA strand was identic in each sample. 
 
Table 2.4: Click screening with the picolyl azide-PEG11-TES protected alkyne linker 37. [*] The percentage of 




Stoichiometric                                  
ratio                           
linker/alkyne 
Stoechiometric                                  














2 10 2 65.2 
3 20 2 77.2 
4 5 5 >99.9 
5 10 5 >99.9 
6 20 5 86.6 
7 5 10 >99.9 
8 10 10 >99.9 
9 20 10 >99.9 
 
 





From 5 equivalents of copper to the alkyne ODN, almost every reaction proceeded in a 
quantitative manner with percentages of conversion higher than 95 %. In this regard, the 
stoichiometric rates of the sample 4 were chosen as the references since they were the one using 
the least amount of linker (5 equivalents as well). While the HPLC profile of the crude products 
show some additional signals than the one corresponding to the target product, this last one 
was nevertheless easily isolated and purified by preparative HPLC (Figure 2.7). 
 
 
Figure 2.7: (A) HPLC profile of the crude product from the sample 4 (see Tab. 2.4). The starting materials, 
alkyne-carrying ODN (red dotted) and the the picolyl azide-PEG11-TES protected alkyne linker 37 (green dotted) 
are depicted for comparison. (B) HPLC profile of the purified product from sample 4 and the corresponding 
MALDI-TOF spectrum (inset). 
 
Once purified, the DNA strand clicked with the picolyl azide-PEG11-TES protected alkyne 
linker 37 was subsequently treated with a sodium fluoride aqueous solution in order to free the 
alkyne from its protecting group. The deprotection was completed in 48 hours at 40 °C and 
provided the deprotected ODN as the only product of the reaction (Figure 2.8). This was 
confirmed by analysing the crude product by MALDI-TOF mass spectrometry. The spectrum 
obtained, shows only one signal corresponding to the target product. The HPLC profile of the 
crude product showing a quite clean product, we decided that this procedure does not require 
an additional purification by preparative HPLC. The functionalized ODN was only desalted on 
a centrifugal membrane filter to get rid of the salts from the deprotection reaction before further 
experiments. 
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Figure 2.8: Analysis of the crude product from the deprotection of the TES protected alkyne ODN. (A) Mass 
spectrometric data. (B) HPLC profile. The starting material, TES protected alkyne ODN, is depicted for 
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We subsequently investigated the clicking ability of the picolyl azide/bis-TES protected alkyne 
linker 40. As previously, the linker was clicked to a 11-mer ODN containing one C8-alkyne-
dU modified nucleoside with standard click reagents (copper sulfate as source of metal catalyst; 
sodium ascorbate as reducing agent; BTTAA as a copper (I) stabilizing ligand). For the 
screening of this linker we kept a stoichiometric ratio of copper (I) to alkyne ODN constant 
and equal to 10 equivalents for all the samples. Only the effect of the ratio of linker (from 5 to 
50 equivalents) on the reaction was studied in this test (Table 2.5). Again, every reaction was 
performed in parallel, for the same time duration and at the same temperature. The final 
concentration of DNA strand was also identical in each sample. 
 
Table 2.5: Click screening with the picolyl azide/bis-TES protected alkyne linker 40. [*] The percentage of 
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linker/alkyne 
Stoechiometric                                  














2 10 10 18.9 
3 20 10 33.1 
4 50 10 45.2 
 
 
Unfortunately, the coupling efficiency of this linker upon click reaction remained relatively 
low despite the higher stoichiometric ratios tried. The highest percentage of conversion 
obtained was of 45 % and it required 50 equivalents of linker. Indeed, analysis of the HPLC 
profile of the crude product shows that most of the alkyne ODN remained unclicked. (Figure 
2.9).  Likewise, if the MALDI-TOF spectrum of the crude product enables the detection of the 





target compound, the main signal came from the unclicked alkyne ODN (Calcd [M-H]- = 
3346.2; Found  [M-H]- = 3341.6). One plausible explanation for the lack of efficiency of this 
linker in comparison to the other linkers previously studied could be a lower water solubility. 
Indeed, we observe upon its addition to the aqueous reaction mixture that this reaction mixture 
became slightly cloudy. This indicates a precipitation. In addition, in the click reactions 
described in the previous sections, the unclicked linkers in excess were eluted during the elution 
with a gradient of 0 to 90 % of buffer B over 45 minutes. However, the picolyl azide/bis-TES 
protected alkyne linker did not appear on the HPLC profiles of the crude products from the 
click reactions. Since the samples are filtered before being injected in the HPLC, if the linker 





Figure 2.9: Analysis of the crude product from the sample 4. (A) HPLC profile. The starting material, alkyne 
ODN, is depicted for comparison (pink dotted). (C) MALDI-TOF spectrum.
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2.4 ODN design and synthesis 
2.4.1 Design parameters 
As described in the objectives section, the CLICKPLA features four oligodeoxyribonucleotides: 
one long template and three smaller strands. The first step of the CLICKPLA being the 
simultaneous hybridization of the three probes on the template, we had to design 
complementary DNA strands with optimal hybridization potentials. In this regard, several 
parameters such as the length of the oligonucleotides needed to be optimal.[105] Too short 
probes would result in unspecific hybridization. Too long probes might require longer 
hybridization time. Too long probes could also increase the risk of having complementary 
regions within the probes themselves, which could result in the formation of hairpin structures 
inhibiting the hybridization with the target strand. The base composition of the oligonucleotides 
should be about 40 to 60 % of G-C to keep the duplex more stable. Eventually, sequences with 
long stretches of a same base should be avoided. The step following the hybridization of the 
three probes on their template is to conjugate them by click chemistry. In order to make this 
conjugation likely to take place and since the modifications bearing the clickable chemical 
functions will be remoted from each other, the modifications need to be smartly placed within 
each probes. The double helix formed by the hybridization of DNA strands is a three-
dimensional structure with a pitch of 10.5 base pairs.[21] Therefore, it has been shown that 
coupling across one complete turn of the double helix is possible since the modifications will 




Figure 2.10: Coupling across the DNA double helix. 





2.4.2 ODN synthesized 
Based on the parameters previously described, we designed two sets of oligonucleotides for 
the CLICKPLA with each set including three functionalized probes and one template strand 
(Figure 2.11). We chose 11-mer probes for the first set of oligonucleotides (ODN-1, ODN-2 
and ODN-3) and a 39 base pairs long complementary template (ODN-4). For the second set, 
three 15-mer probes were designed (ODN-5, ODN-6 and ODN-7) and a corresponding 
template strand of 45-mer (ODN-8). The sequences of the template were taken from the single 
stranded plasmid M13mp18. The incorporation site of the C8-alkyne-dU nucleoside within the 
sequence of each probe was chosen in order to have an 8 bp distance until the next modification 
once the probes hybridized in order to increase the chances of conjugation between the probes.  
 
 
Figure 2.11: Sequences of the two sets of DNA strands designed for the CLICKPLA. The base N (in red) is the 
modified nucleoside. 
 
In the objectives part of this chapter, two versions of the CLICKPLA had been envisioned. In 
the first one, the two side probes would each carry an azide function and the middle probe 
would bear two alkynes. In the second version, the side probes would carry the alkyne functions 
whereas the middle probe would be the azides bearing one. Considering the coupling 






  ODN1            3' CGACGACNCCCACTGCNAGGGCGTTNTCGCCGG 5‘ ODN3 






                            
 ODN5  3' AGGGTTTACCGAGNTCAGCCACNGCCACTATNAAGTGGAAATTAC 5‘ ODN7 












Figure 2.12: Schematic representation of the CLICKPLA version selected. The oligonucleotide probes are 
represented in green. The oligonucleotide templates is in purple. At first, three probes are hybridized to the 
complementary template. In a second time, the click reaction between the alkyne side probes and azide middle 
probe can be initiated and the three probes are conjugated to each other.   
 
Indeed, both the picolyl azide-PEG11-TES protected alkyne linker 37 and the picolyl azide/bis-
azide linker 19 provided high coupling efficiencies upon click reaction with alkyne-modified 
oligonucleotides. Therefore, we decided to functionalize the side side probes of each set 
(respectively ODN-1and ODN-3 for the first set and ODN-5 and ODN-7 for the second set) 
with the picolyl azide-PEG11-TES protected alkyne linker 37. The middle probes were 
functionalized with the picolyl azide/bis-azide linker 19 in order to bear two azides. All the 
oligonucleotides synthesized and functionalized for both sets are recapitulated in the following 
table (Table 2.6)





Table 2.6: Mass spectrometric data of the oligonucleotides synthesized for the CLICKPLA. [*] The strands 






ODN-1 5' CCC-C8-Alk-dU-CAGCAGC 3' 3351.1 3347.2 
ODN-2 5' CGGGA-C8-Alk-dU-CGTCA 3' 3346.2 3441.6 
ODN-3 5' GGCCGCT-C8-Alk-dU-TTG 3' 3428.2 3424.8 
ODN-4* 5' TTCGCTGCTGAGGGTGACGATCCCGCAAAAGCGGCCTTT 3' 11998.8 - 
ODN-5 5' T-C8-Alk-dU-GAGCCATTTGGGA 3' 4712.0 4710.6 
ODN-6 5' ATCACCG-C8-Alk-dU-CACCGAC 3' 4571.0 4567.6 
ODN-7 5' CATTAAAGGTGAA-C8-Alk-dU-T 3' 4704.1 4699.6 
ODN-8* 5' TCCCAA ATGGCTCAAGTCGGTGACGGTGATAATTCACCTTTAATG 3' 13840 - 
    
ODN-2-BisAz 5' CGGGA-BisAz-CGTCA 3' 4292.6 4288.0 
ODN-6-BisAz 5' ATCACCG-BisAz-CACCGAC 3' 5417.3 5415.1 
    
ODN-1-TES 5' CCC-TES-CAGCAGC 3' 4249.7 4246.5 
ODN-3-TES 5' GGCCGCT-TES-TTG 3' 4326.7 4322.7 
ODN-5-TES 5' T-TES-GAGCCATTTGGGA 3' 5610.5 5610.0 
ODN-7-TES 5' CATTAAAGGTGAA-TES-T 3' 5602.6 5596.5 
    
ODN-1-Alk 5' CCC-Alk-CAGCAGC 3' 4135.6 4129.9 
ODN-3-Alk 5' GGCCGCT-Alk-TTG 3' 4212.6 4208.7 
ODN-5-Alk 5' T-Alk-GAGCCATTTGGGA 3' 5496.5 5491.0 
ODN-7-Alk 5' CATTAAAGGTGAA-Alk-T 3' 5488.5 5483.2 
 
  





2.4.3 Melting temperature (Tm) measurement 
Each functionalized probe was added alone in solution to its corresponding template and the 
melting temperature was measured by following the UV-vis signal at 260 nm upon several 
cycles of heating and cooling. The resulting absorption profiles and the temperatures 
determined from them are shown in the figure 2.13. This experiment was performed in order 
to control that every oligo probe functionalized with a linker was able to form properly a 




Figure 2.13: Melting profiles of (A) ODN-1-Alk, ODN-2-BisAz and ODN-3-Alk with the template ODN-4; (B) 
ODN-5-Alk, ODN-6-BisAz and ODN-7-Alk with the template ODN-8. 
 
The melting temperatures were also measured as an indication of within which range of 
temperatures, the click reaction of the CLICKPLA could be performed. Indeed, the probes 
designed being relatively short and particularly for the ones from the 11-mer set, it was 
important to ensure that the hybridized duplex would remain stable during the click 
conjugation. All the profiles obtained provided melting temperatures superior than 45 °C. We 
assumed therefore that the duplex of both sets should remain hybridized at the usual room 
temperature condition used for click reaction with oligonucleotide. 
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2.4.4 Click test with dyes 
In order to test that the synthesized and functionalized oligonucleotides are indeed functional 
towards further click reactions, we conjugated them with organic dyes. Thus, coumarin azide 
41 and fluorescein alkyne 42 were clicked respectively on the strands bearing the alkyne linker 
and the strands bearing the bis-azide linker. This test had no other purpose than assessing the 
formation of the clicked adduct. We therefore investigated the crude reaction products only by 
MALDI-TOF mass spectrometry (Table 2.7). Indeed, every functional oligonucleotide, only 
the target product was detected confirming so the expected reactivity of the probes synthesized 
for the CLICKPLA. 
 






ODN-1 Coumarine 5' CCC-AlkCoumarin-CAGCAGC 3' 4338.6 4334.5 
ODN-3-Coumarine 5' GGCCGCT-AlkCoumarin-TTG 3' 4415.6 4411.3 
ODN-5-Coumarine 5' T-AlkCoumarin-GAGCCATTTGGGA 3' 5699.5 5695.3 
ODN-7-Coumarine 5' CATTAAAGGTGAA-AlkCoumarin-T 3' 5691.5 5686.5 
    
ODN-2-BisFluoresceine 5' CGGGA-BisAzFluoresceine-CGTCA 3' 5118.8 5116.4 
ODN-6-BisFluoresceine 5' ATCACCG-BisAzFluoresceine-CACCGAC 3' 6243.5 6239.6 
 
 





2.5 CLICKPLA experiments 
2.5.1 Double conjugation experiments  
Once all the oligonucleotides probes had been synthesized, functionalized and tested regarding 
their ability to form a duplex with their templates and their click reactivity, we performed the 
first CLICKPLA experiments. To do so, all the ODN of a given set were mixed together and 
concentrated. After hybridizing the three probes on the respective template, a sample was taken 
out as a negative control and the click catalyst Master Mix containing copper sulphate, sodium 
ascorbate and the chelating agent BTTAA was added (see Experimental part). In parallel, a 
second reaction tube containing only the three probes without the template was prepared and 




Figure 2.14: 20% denaturing PAGE from the CLICKPLA experiment with the 11-mer probes. Lanes 1 to 4 contain 
respectively ODN-1-Alk, ODN-2-BisAz, ODN-3-Alk and ODN-4. The lane C1 is a control with all the ODN 
from the 11-mer set hybridized but not clicked. The lane RP is the click reaction product with all the ODN from 
the 11-mer set. C2 is a control with the 11-mer probes clicked in the absence of template. C1 = control 1; C2= 
control 2; RP = reaction product. 
 
11-mer probes  
39-mer template 
Single conjugated products 
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The click reactions were analysed by denaturing urea polyacrylamide gel electrophoresis. 
Figure 2.13 shows the results for the 11-mer set consisting of ODN-1-Alk, ODN-2-BisAz, 
ODN3-Alk and ODN-4. Lane C1 contains the sample that was taken out of the reaction tube 
containing all the ODN of the set prior to the addition of the click catalyst Master Mix. As no 
click reaction took place and since the reaction products were analysed on a denaturing gel, we 
can expectedly observe the three probes and the template separated from each other at their 
respective running distances as verified by the individual strands applied in lanes 1-4. In the 
lane RP, which corresponds to the complete 11-mer set after the click, we can again observe a 
band from the template ODN-4. However, the bands corresponding to the three probes have 
significantly faded and three new bands are visible instead. The first two new bands have 
similar electrophoretic mobilities, which are slightly higher than the 39-mer template and lower 
than the ones of the 11-mer probes. Therefore, we assumed that these two bands correspond to 
the single conjugated products of ODN-1-Alk/ODN-2-BisAz and ODN-3-Alk/ODN-2-BisAz. 
More interestingly, the third new band in the reaction product lane has an even lower mobility 
than the template indicating a higher size. The modified ODNs being bulkier than normal DNA, 
we expected that their conjugate would run significantly slower on the gel. Thus, we assigned 
this band as the target double conjugated product of the three probes and thus that the template 
assisted click conjugation between the three functionalized oligonucleotides was successful. 
Eventually, the lane C2 shows the product of the control reaction in the absence of template. 
While the bands assigned to the single conjugated products and more important the one 
assigned to the target double conjugated product can still be observed, their intensity is lower, 
even though approximately the same amount of material was loaded in each lane. This indicates 
that although the double click reaction can happen in the absence of template and within the 
conditions employed here ([ODN] = 10 µM; reaction time: 3 hours at room temperature), the 
presence of a template provides a major enhancement to the efficiency of the reaction. 
 
The same experiments were also performed with the 15-mer set of probes consisting of ODN-
5-Alk, ODN-6-BisAz, ODN-7-Alk and ODN-8.  The analysis of these samples using 
denaturing PAGE is shown in Figure 2.15.  
 







Figure 2.15: 20% denaturing PAGE from the CLICKPLA experiment with the 15-mer probes. Lanes 1 to 4 contain 
respectively ODN-5-Alk, ODN-6-BisAz, ODN-7-Alk and ODN-8. The lane C1 is a control with the all the ODN 
from the 15-mer set hybridized but not clicked. The lane RP is the click reaction product with all the ODN from 
the 15-mer set. C2 is a control with the 15-mer probes clicked in the absence of template. C1 = control 1; C2= 
control 2; RP = reaction product. 
 
In lane, C1, which contains the complete 15-mer set without click, we can observe clearly and 
well resolved the three bands of ODN-5-Alk, ODN-6-BisAz and ODN-7-Alk as well as the 
one of the template ODN-8. Analogous to the results for the 11-mer set, while the template is 
equally visible in the lane where the actual click reaction product was applied (lane RP), the 
lanes of the 15-mer probes are only faintly visible and three new bands can be observed. 
Although not as well resolved as on the gel of the 11-mer set (Figure 2.13), there are still two 
bands with similar electrophoretic mobility as the template. These bands are assumed to be the 
single conjugated products of ODN-5-Alk clicked to ODN-6-BisAz and ODN-7-Alk with 
ODN-6-BisAz. The third new band, higher again on the gel than the 45-mer template is 
attributed to the target double conjugated product. The reaction control without template shows 
clearly the formation of the single conjugated products. However, the band assigned to the 
15-mer probes  
45-mer template Single conjugated products 
Double conjugated product 
1 2 3 4 C1 RP C2 





double conjugated product is almost not visible this time. To the longer probe ODNs seem to 
correspond less unwanted conjugation in the absence of the template. This result confirms that 
the template assisted double click reaction is very effective. On the other hand, the probability 
for the middle probe to be clicked with both side probes remains very low without the proximity 
effect provided by the template and placing them next to each other upon hybridization. 
  
2.5.2 Concentration experiments 
Encouraged by the template assisted double conjugation results with both the 11-mer set and 
the 15 mer set, we decided to investigate if the template assistance can enable the reaction to 
proceed at lower concentrations. The reactions described in the previous section were 
performed at a final concentration of oligonucleotides of 10 µM. For the following 
experiments, we used the 11-mer probes (ODN-1-Alk, ODN-2-BisAz and ODN-3-Alk) as well 
as their template (ODN-4) and several reactions were carried out with different concentrations 
of oligonucleotides ranging from 10 µM down to 0.1 µM. For every reaction, a reaction control 
without the template was performed in parallel. The reaction products were again analysed by 




Figure 2.16: 20% denaturing PAGE from the CLICKPLA experiments with the 11-mer probes at different 
concentration. Lanes 1 to 6 contain the reaction controls with ODN-1-Alk, ODN-2-BisAz, ODN-3-Alk and 
without template. The lanes 7 to 12 contain the reaction with ODN-1-Alk, ODN-2-BisAz, ODN-3-Alk and ODN-
4. 
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In lanes 11 and 12, which correspond to the reactions performed at 5 and 10 µM respectively, 
we can observe a very strong band for the target double conjugated product. At lower 
concentration than 5 µM, this band can still be observed but its intensity decreases along with 
the concentration. The same is observed for the reaction controls, although as expected the 
target double conjugated product band is less strong than the one corresponding to the reactions 
in the presence of template. 
 
2.5.3 Reaction time experiments 
After testing different final concentrations of oligonucleotides, we envisioned to perform the 
double click conjugation with different durations. Indeed, so far every reaction performed had 
been ran for 3 hours. Here, we decided to test whether the reaction could be achieved within 
15, 30 or 60 minutes. In addition, we decided to use a different reaction temperature for these 
tests by heating the reaction at 40 °C whereas the previous reactions had been performed room 
temperature. As shown in section 2.4.3, all the ODN probes have a melting temperature higher 
than 45 °C. Therefore, we assumed that a reaction at 40 °C should not cause stability issue to 
the duplex formed by the probes with the template. On the other hand, we were curious to test 
if slightly increasing the reaction temperature while running the reaction for shorter times could 
prevent the formation of the double conjugated product in the absence of template. For these 
experiments, we used the 15-mer probes (ODN-5-Alk, ODN-6-BisAz and ODN-7-Alk) and 
the corresponding template (ODN-8). The reactions were ran in parallel and stopped at 
different intervals. In order to stop the reactions at defined times, the reaction mixtures were 
diluted in water by a factor 100 and directly desalted on a centrifuge membrane filter in order 
to wash the copper catalyst away. For every reaction, a control was performed simultaneously 
without the template. The ODN concentration was the same in every reaction tube and equal 
to 10 µM. The denaturing PAGE obtained from analysis of these samples is shown in figure 
2.17. In the lane 4 to 6, where the reaction mixtures in presence of template were applied, we 
can observe an intense band for the double conjugated product. Quite impressively, it seems 
that the double click reaction is already effective after 15 minutes. This is even more striking 
considering the low concentration at which the reactions took place. Moreover, in the lanes 
where the products from the reaction controls without template were applied, we could barely 
observe, if at all, the formation of the double conjugated product. On the other hand, the 





unclicked probes were still clearly observable in these lanes. These results confirm that the 





Figure 2.17: 20% denaturing PAGE from the CLICKPLA experiments with the 15 mer probes clicked with 
different reaction times. Lanes 1, 2 and 3 contain the reaction controls with ODN-5-Alk, ODN-6-BisAz, ODN-7-
Alk and without template. The lane 4, 5 and 6 contain the reaction with ODN-5-Alk, ODN-6-BisAz, ODN-7-Alk 
and ODN-8.
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2.6 Conclusions and Outlook 
Proximity ligation assay is a very sensitive method developed for the detection of proteins and 
based on DNA amplification.[1] Since the original proof of concept reported by Landegren et 
al. in 2002, the PLA and variation of the original concept have been employed in a wide range 
of applications.[80] 
The project presented in this chapter aimed at investigating if the CuAAC reaction could in 
theory enhance the existing PLA methods.  As a proof of concept, we designed a model where 
three click functional oligonucleotide probes are hybridized next to each other on a single 
longer oligonucleotide. The latter one, acting as a template, would enable the probes to be 
hybridized next to each other and facilitate further conjugation by click chemistry. 
The first part of the project was to synthesize linkers enabling the desired functionalization of 
oligonucleotides. At first, we synthesized two unsymmetrical linkers with respectively one 
picolyl azide/one non-chelating azide and one picolyl azide/two non-chelating azides. These 
linkers could be chemoselectively clicked on alkyne modified DNA strand thanks to the picolyl 
azide and thus leaving the non-chelating azide(s) free for subsequent reactions. Next, we 
synthesized unssymetrical linkers with a picolyl azide and one or two protected alkyne groups.  
After clicking these linkers to alkyne modified DNA strands thanks to their picolyl azide 
moiety, the alkyne of the linker was freed from its protecting group rendering it functional 
towards further click reactions. 
The strategies thus developed enabled the synthesis of two sets of oligonucleotide probes with 
11- and 15- mer strands respectively. Each set featured three probes, two single alkyne 
functionalized side probes and one double azide middle probe as well as a complementary 
oligonucleotide template. Both sets of probes were hybridized on their respective template and 
conjugated to each other by click reaction. Analysis by denaturing PAGE showed the 
successful formation of the double conjugated product with both sets of probes. Moreover, we 
demonstrated that the proximity effect created by the hybridization of the probes on their 
template was an essential component to the double conjugation between the three probes.  
In conclusion, an oligonucleotide template was used to mimic the proximity effect found in 
PLAs. After hybridization on this template, three beforehand functionalized oligonucleotide 
probes were conjugated to each other by click chemistry. This model based on three probes 
could be applied in a Triple Proximity Ligation Assay in the future as following. After 
recognition of a three-protein complex by three proximity probes, three click functional 





oligonucleotides are added and hybridized to the oligonucleotides on the proximity probes. 
After washing the non-hybridized clickable oligonucleotides, addition of a copper catalyst 
solution will result in the formation of a double conjugated product between the three 
hybridized proximity probes. This double conjugated product will then serve as a template in 
its turn for the circularization of three linear oligonucleotide connectors by enzymatic ligation.  
In theory, the circular strand thus generated could be formed only in the presence of the double 
conjugated product which itself accounts for the presence of the protein (or protein complex) 
of interest. One of the extremities of the double conjugated product will serve as a primer and 
the circular strand will be amplified by RCA upon addition of a DNA polymerase. The 
amplification product will eventually be detected by fluorescence in situ hybridization (FISH) 



























































Scheme 2.11: Presentation of a triple proximity ligation assay based on click chemistry. If three proximity probes 
are close to each other (pink, blue, red), by binding a same three-protein complex (green, yellow, bright blue), 
then subsequently added click functional ODN probes (green) can be hybridized to the proximity probes and 
conjugated to each others by CuAAC. The double conjugated product can further act as a template to linear ODN 
connector (orange) to form a circular structure covalently joined by enzymatic DNA ligation. RCA is then initiated 
by using the double conjugated product as a primer. The RCA product is detected by FISH. 





3. SYNTHESIS AND INCORPORATION OF 5-CARBOXYCYTIDINE 
PHOSPHORAMIDITE IN SYNTHETIC RNA 
3.1 Objectives 
5-Hydroxymethyl-[108, 109], 5-formyl-[110], and 5-carboxycytidine[111] bases (respectively 
abbreviated hmdC, fdC and cadC) are modified bases that were discovered in the DNA of 
higher eukaryotes. Since their discovery, it has been established that these bases are 
dynamically generated and removed to regulate the transcriptional activity of genes and 
therefore possess an epigenetic role. Indeed, they are oxidized derivatives of mdC, which is 
well known for silencing the gene transcription in the promoters where it is found.[112, 113, 114, 
115, 116, 117] 
More recently, mC[9], fC[10, 11, 12] and caC[13] have also been found in messenger RNA of 
mammalian cells. It was recently proven that the so-called ten-eleven translocation (TET) 
enzymes, the protein family responsible for the oxidation of the DNA base mdC, can also 
oxidize the RNA base mC subsequently into hmC, fC [11] and caC [118]. In theory, this could 
indicate a link between DNA and RNA epigenetics[11, 118], as well as a role from these bases in 
the regulation of the biosynthesis of proteins.[119, 120] Overall, their actual functions remain to 
to be elucidated and in order to do so, it is necessary to develop phosphoramidite building 




Figure 3.1: Depiction of the three RNA nucleoside modifications hmC, fC and caC. 
 





Indeed, this would provide access to synthetic RNA strands with one or several of these 
modifications, which could in turn be used in studies aiming at deciphering the functional 
consequences of hmC, fC and caC in RNA. Phosphoramidite building blocks for hmC and fC 
have already been reported by respectively Micura[121, 122] and Deiters[123]. However, these 
building blocks require specific conditions for their incorporation into RNA strands. Therefore, 
phosphoramidite building blocks for hmC, fC as well as caC able to be incorporated with 
standard solid-phase RNA synthesis conditions still needed to be developed. Moreover, such 
building blocks would enable the incorporation of the three modifications in a one single strand. 
The goal of this project was therefore the development of a synthesis route towards a caC RNA 
phosphoramdite building block compatible with standard RNA solid-phase synthesis. In 
parallel to the synthesis of the caC building block, described in the present chapter, the 
synthesis routes towards a fC RNA phosphoramidite building block as well as a hmC one were 
developed by co-members of the Carell Group, Dr. Nobuhiro Tago and Dr. Iacovos 
Michaelides. In a joint effort, we further aimed at incorporating all the three C modification 









3.2 Design and protecting group strategy 
In order to synthesize a caC RNA phosphoramidite, we needed to develop an alternative 
protecting group strategy to the one employed for the corresponding DNA building block.  
The RNA molecule is intrinsically more sensitive than the DNA one due to the 2’-OH on the 
ribose. The latter, upon deprotonation, can attack as a nucleophile the adjacent phosphorous in 
the phosphodiester bond leading to the cleavage of the RNA backbone. Because of this 
chemical instability, silyl groups usually protect the 2’-OH RNA phosphoramidite building 
blocks and their removal by a fluoride source (commonly with the trimethylamine 
trihydrofluoride reagent[124]) is the last treatment that the synthetic RNA strand undergoes. Here 
we chose to use a TBS group for the protection of 2’-OH position of the ribose. For the 
protection of the exocyclic amine N4, we decided to use a p-methoxybenzoyl group, which can 
be easily removed at the same time as the cleavage of the strands from the solid support during 
the ammonolysis step. The carboxylic acid on the position 5 of the caC DNA phosphoramidite 
is generally protected by alkyl ester groups such as trifluoroethyl ester[125] or methyl ester[126]. 
Once the building block is incorporated inside the synthetic strand, these protecting groups are 
removed by hydrolysis with aqueous NaOH instead of ammonolysis, which could result in the 
formation a 5-carboxamide side product. However, we assumed that such harsh condition are 
not compatible with RNA synthesis. The silyl protecting group of the 2’-OH on the ribose 
could be removed as well during this treatment, resulting in the cleavage of the synthetic RNA 
strand.  Therefore, we chose instead to protect the carboxylic acid group with a p-
nitrophenylethylester group. The latter can be cleaved in milder condition using DBU in THF 
at room temperature prior to the ammonolysis and thus preventing the formation of a 5-
carboxyamide side product. The caC RNA phosphoramidite 42 thus envisioned is depicted in 
scheme 3.1.
 






Scheme 3.1: Structure of the caC RNA phosphoramidite building block 42 designed.  
 
After the incorporation of one or several caC phosphoramidite by automatic solid phase 
synthesis, we imagined the deprotection of the different moieties according to the following 
sequence: 
1- Phosphodiester bonds; 
2- 5-carboxilic acid; 
3- N4-amine deprotection // cleavage from the solid support; 
4- 2’-OH deprotection. 
 
A non-nucleophilic base could simultaneously remove the cyanoethyl group and the p-
nitrophenylethylester group, respectively protecting the phosphodiester bond and the 5-
carboxilic acid. However, in order to avoid potential Michael-type addition, the 5-carboxilic 
acid was deprotected after the phosphodiester linkage. Indeed the deprotection of the latter 
generates acrylonitrile, which could add itself to the base of the nucleoside, and the Michael-












3.3 Synthesis of a caC RNA phosphoramidite building block 
Starting from 3´,5´-O-(di-tert-butylsilanediyl)-2´-O-tert-butyldimethylsilyl-cytidine 43, the 
nucleoside moiety was iodinated in position 5 by a treatment with iodine in the presence of 
ceric ammonium nitrate. The iodinated product 44 was obtained with a 49 % yield. Following 
a procedure from Nomura et al.[133], 44 was subsequently converted into the corresponding p-
nitrophenylethylester 45 in 52 % yield. This was achieved by the mean of a palladium catalyzed 
carbon monoxide insertion in the presence of p-nitrophenethylalcohol. The N4-amine was 
reacted in turn with the acylating agent p-anisoyl chloride leading to its protection as a 
methoxybenzoyl amide 46. The latter compound 46 was obtained in a 81 % yield. The 
following reaction consisted in the cleavage of the silyl group protecting simultaneously the 3’ 
and 5’ position of the nucleoside. This cleavage was achieved with a solution of HF in pyridine 
and provided the compound 47 with 89 % yield. The nucleoside was eventually DMT-protected 
(95 % yield) and phosphorylated (75 % yield) with standard nucleoside chemistry 
procedures[134, 135]. The caC RNA phosphoramidite building block 42 was thus obtained ready 
for use with an automatic oligonucleotide synthesizer. 







Scheme 3.2: Synthesis of the caC RNA phosphoramidite building block 42.





3.4 Solid phase synthesis of RNA strands containing caC 
Following the synthesis of the caC RNA phosphoramidite buiding bock 42, we aimed at testing 
its compatibility with automated solid phase synthesis and validating the deprotection protocol 
designed for this building block. Therefore, we incorporated the caC phosphoramidite 
synthesized 42 in two different RNA strands. A short one (13mer) and a long one (21mer) 
respectively designated ON-1 and ON-2 (Table 3.1).  
 






ON-1 5' CCUACcaCGCAUUAC 3' 4061.6 4057.7 
ON-2 5' UCUGAGUCCCUAUUAcaCAAGAG 3' 6696.9 6690.9 




    
 
 
During the solid phase synthesis, the coupling time of the special caC phosphoramidite 42 was 
extended to 20 minutes (instead of 10 minutes for the standard RNA phosphoramidites) in 
order to ensure the highest possible coupling yield. According to the deprotection strategy 
envisioned in the section 3.2, once the synthesis achieved, the solid support was treated with 
DBU in acetonitrile for 1 to 3 minutes to cleave the cyanoethyl group protecting the 
phosphodiester bound. This solution was then replaced by one with DBU in THF and the 
deprotection of the carboxyl group was achieved after 2 hours. The oligonucleotides were 
further treated with standard deprotection conditions to remove the remaining labile groups. 
Thus, cleavage from the solid support and cleavage of the N4 amino protecting group were 
achieved by exposure to an ammonium hydroxide solution in ethanol. Eventually, the TBS 
group was removed from the 2’-OH with a trimethylamine trihydrofluoride solution in DMSO. 
The crude products of ON-1 and ON-2 synthesis were analysed by MALDI-TOF mass 





spectrometry and it was possible to detect the mass corresponding to both full-length strands 
containing the caC modification. Both oligonucleotides were further purified and successfully 




Figure 3.2: (A) HPLC profile of the crude product from the synthesis and deprotection of ON-1. (B) HPLC profile 
of the purified product from the synthesis and deprotection of ON-1 and the corresponding MALDI-TOF spectrum 
(inset). (C) HPLC profile of the crude product from the synthesis and deprotection of ON-2. (B) HPLC profile of 
the purified product from the synthesis and deprotection of ON-2 and the corresponding MALDI-TOF spectrum 
(inset). 
 
A                                                         B 
C                                                         D 





3.5 Solid phase synthesis of a RNA strand containing all the C modifications 
As mention in the objectives part of the present chapter, new RNA phosphoramidite building 
blocks for the fC 49 and hmC 50 modifications were prepared along in the Carell Group (see 
Scheme 3.3). Like the caC building block 42 here reported, these two fC 49 and hmC 50 
building blocks have been designed in order to be compatible with standard RNA solid phase 
synthesis and deprotection. Therefore, the three newly synthesized C modifications building 
blocks should be compatible with each other and we decided to investigate this eventuality by 




Scheme 3.3: Structure of the hmC 50 and fC 49 RNA phosphoramidite building block incorporated together in 
the same RNA strand with the caC one 42. 
 
The sequence of the oligonucleotide containing one of each C modification is depicted in the 
Table 3.2. The coupling time for the special C modifications phosphoramidites was extended 
to 20 minutes, here again in order to maximise the synthesis yield. Subsequent to the solid 
phase synthesis, we applied to this strand the same deprotection protocol as the one described 
previously for the caC containing strands ON-1 and ON-2. The oligonucleotide underwent a 
final treatment with citric acid-sodium citrate buffer at pH 4 to eventually remove the acetal 










Table 3.2: Mass spectrometric data of the oligonucleotide synthesized containing hmC, fC and caC modifications. 
Entry Sequence Calcd [M-H]- Found [M-H]- 





MALDI-TOF analysis of the crude product from the deprotection of ON-3 allowed the 
detection of the correct mass of the full-length synthetic RNA strand with the three C modified 
nucleosides. Moreover, analysis of the crude product by HPLC provided a relatively clean 
profile (Figure 3.3). This can be attributed to an effective synthesis and incorporation of all the 
three special phosphoramidite building blocks as well as an effective deprotection protocol 
preventing the formation of any major side products. Finally, the synthetic RNA strand 
containing caC, fC and hmC nucleosides was successfully purified and isolated by HPLC (see 
Figure 3.3). 
 
Figure 3.3: (A) HPLC profile of the crude product from the synthesis and deprotection of ON-3. (B) HPLC profile 
of the purified product from the synthesis and deprotection of ON-3 and the corresponding MALDI-TOF spectrum 
(inset).
A                                                         B 





3.6 Enzymatic digestion and uHPLC-MS analysis 
In order to confirm the identity and the integrity of the C modifications incorporated by solid 
phase synthesis, the RNA strand ON-3 containing hmC, fC and caC was enzymatically digested 
to cleave the strand into single nucleosides. The resulting mixture was subsequently analysed 
by UHPLC-MS and allowed the detection of all the nucleosides present in the strand (Figure 
3.4). In addition to the four canonical nucleosides, we were able to detect the three C modified 
nucleosides. Moreover, the HPLC profile obtained shows only the four signals corresponding 
to the canonical nucleosides and the three signals corresponding to hmC, fC and caC. Thus, the 
absence of additional signal confirms that the incorporation of the special phosphoramidites 
and deprotection of the resulting RNA strand proceeded effectively and without the formation 




Figure 3.4: UHPLC profile of the enzymatically digested ON-3 allowing the detection of hmC, fC and caC in 
addition to the four canonical nucleosides A, C, G and U. 





 3.7 Conclusions and Outlook 
In a team effort from the Carell Group, we synthesized new RNA phosphoramidite building 
block of hmC 50, fC 49 and caC 42. Well-designed deprotection strategies enabled efficient 
incorporation of these building blocks by automated solid phase synthesis inside RNA strands 
of different lengths.  The newly developed modified cytosine building blocks have indeed 
allowed the synthesis of a strand containing all the three epigenetic bases at specific sites.   
It will now be possible to start investigating the role of these modifications inside RNA by 
performing biochemical studies based on synthetic RNA material containing one or several of 
the C(5) modified cytosine bases. We envisioned for example similar experiments to those 
previously performed in our group to study the role of hmC, fC and caC in the context of 
DNA.[136] In short, we could incubate nuclear extracts from selected cell-line with RNA strands 
containing the modified bases. The proteins interacting with the modified bases could be 
further isolated in a pull-down assay and analysed by quantitative mass spectrometry. The 
identification and study of the proteins recognizing hmC, fC and caC in RNA could thus lead 
to decipher how these bases are dynamically formed and their intrinsic exact functions.  






4.1 General Methods and Materials for Synthesis 
Chemicals were purchased from Sigma Aldrich, ABCR, Alfa Aesar, Acros Organics, Tokyo 
Chemical Industry Co. or Carbosynth and used without further purification. The solvents for 
organic synthesis were of reagent grade and purified by distillation. Dry solvents were bought 
from Sigma Aldrich and Acros Organics. Acetonitrile for HPLC purification was purchased 
from VWR. ddH2O refers to double distilled water and was obtained by a Milli-Q® Plus 
purification system from Merck Millipore using a QPAK® 2 cartridge. 
All reactions were carried out with Heidolph MR3001K magnetic stirring hotplates, and if 
moisture and air sensitive, in oven-dried glassware (>12 h, 110 °C) under nitrogen or argon. 
The temperature of reactions (except room temperature) was adjusted with an acetone/dry ice 
mixture, a water/ice-mixture or an oil bath and the temperature monitored with a Heidolph ETK 
3001 contact thermometer. In vacuo solvent removals and solution reconcentrations were 
performed with a Heidolph Laborota 4000 rotary evaporator with a Vario PC2001 diaphragm 
pump from Vacuumbrand. For the removal of water and acetonitrile by freeze-drying, a Christ 
Alpha 2-4 LD plus lyophilizer was used. Alternatively, a centrifugal evaporator Savant 
SpeedVac® Plus SC110A was used.  
Chromatographic purification of products was accomplished using flash column 
chromatography on Merck Geduran Si 60 (40 – 63 μm) silica gel (normal phase) or by 
reversed-phase high-performance liquid chromatography (RP-HPLC). Thin layer 
chromatography (TLC) was performed on Merck 60 (silica gel F254) plates and visualized under 
UV light (λ = 254 and 366 nm) and staining with ninhydrin solution (0.3 g ninhydrin, 3 mL 
acetic acid in 100 mL n-Butanol), potassium permanganate (1.5 g KMnO4, 10.0 g K2CO3, 125 
mg NaOH in 200 mL water) or ceric ammonium molybdate (10.0 g ammonium molybdate 
tetrahydrate, 2 g Ce(SO4)2∙4H2O, 180 mL ddH2O, 20 mL conc. H2SO4). 
1H-, 13C-, and 31P-NMR spectra were recorded in deuterated solvents purchased from Euriso-
top on Varian Oxford 200, Bruker ARX 300, Varian VXR400S, Varian Inova 400, Brucker 
Avance III (cryoprobe) 400, Brucker AMX 600 and Brucker Avance III HD (cryoprobe) 800 
spectrometers and calibrated to the residual solvent peak using reported values.[137] The 
chemical shifts (d) are given in ppm, the coupling constants (J) in Hz. Multiplicities are 





abbreviated as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad 
and combinations of these. For assignment of the structures, additional 2D NMR spectra 
(COSY, HSQC and HMBC) were measured. High resolution electrospray ionization mass 
spectra (HRMS-ESI) were recorded on a Thermo Finnigan LTQ-FT (ESI-FTICR), and high 
resolution electron impact ionization mass spectra (HRMS-EI) were recorded on a Thermo 
Finnigan MAT 95. Matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) 
mass spectra were recorded on a Brucker Autoflex II. For MALDI-TOF measurements, the 
samples were dialyzed on a 0.025 μm VSWP filter (Merck Millipore) against ddH2O for 1 h 
and then co-crystallized in a 3-hydroxypicolinic acid matrix (HPA: 25 mg 3-hydroxypicolinic 
acid, 5 mg ammonium citrate, 5 μL 15-crown-5 in 0.5 mL H2O/MeCN = 1:1). IR spectra were 
recorded on a Perkin Elmer spectrum BX instrument and are reported as follows: wavenumber 
ῦ in cm–1. The pH values of buffers were adjusted using a MP 220 pH meter (Mettler Toledo). 
UV spectra and melting profiles were measured on a Jasco V-650 spectrometer using quartz 
glass cuvettes with 1 cm path length. The concentration of purified oligonucleotide was 
determined in triplicate with a NanoDrop ND-1000 spectrophotometer from Thermo Scientific 
using calculated extinction coefficient from OligoAnalyzer 3.0 (Integrated DNA Technologies: 
https://eu.idtdna.com/calc/analyzer). For strands containing artificial bases, the extinction 
coefficient of their corresponding control strand was employed without correction. 
 
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC)  
The following devices were used for the analysis and purification of the synthetic DNA/RNA strands 
and the linkers synthesized. In order to remove insoluble particles, samples for preparative HPLC were 
filtered through a 0.2 μm GHP filter membrane (Acrodisc®), and samples for analytical HPLC were 
centrifuged at maximum speed, prior to loading.  
Analytical RP-HPLC was performed on an analytical HPLC Waters Alliance (2695 Separation Module, 
2996 Photodiode Array Detector) equipped with the column Nucleosil 120-3 C18 from Macherey 
Nagel. Using a flow of 0.5 mL/min, gradients of 0–50 % B in 45 min or 0–90 % B over 45 minutes 
were applied. Preparative RP-HPLC was performed on a HPLC Waters Breeze (2487 Dual λ Array 
Detector, 1525 Binary HPLC Pump) equipped with the columns Nucleosil 100-7 C18, VP 250/10 C18 
from Macherey Nagel. Using a flow of 5 mL/min, a gradient of 0–90 % B over 45 minutes was applied 
Buffer systems: Buffer A: 0.1 M triethylammonium acetate in water;  
 Buffer B: 0.1 M triethylammonium acetate in 80% (v/v) acetonitril





4.2 Chemical synthesis 
4.2.1 Synthesis of the picolyl azide-PEG10-azide linker (17)  




2,5-pyridinedicarboxylic acid dimethyl ester (5.23 g, 26.8 mmol, 1.0 eq.) was dissolved in dry 
MeOH/dry THF (2:1, 300 mL) and cooled down to 0 °C. NaBH4 (2.03 g, 53.6 mmol, 2.0 eq.) 
was then added portionwise over 20 minutes. The reaction was stirred at 0 °C for 3 hours before 
being quenched by the addition of a saturated NH4Cl-solution (~ 100 mL). The solvent was 
removed in vacuo and the aqueous layer was extracted with DCM (3 × 100 mL). The combined 
organic layers were dried over MgSO4, filtered and the solvent was removed in vacuo. 6-
hydroxymethyl-nicotinic acid methyl ester was obtained as a colorless solid (3.95 g, 23.6 
mmol, 88 %). 
Rf (iHex/EtOAc, 1/1) = 0.3. 
1H-NMR (400 MHz, CDCl3): δ (ppm): 9.15 (d, J = 2 Hz, 1H), 8.29 (dd, J = 8.1, 1.9 Hz, 1H), 
7.36 (d, J = 8.1 Hz, 1H), 4.83 (s, 2H), 3.95 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 165.6, 163.4, 149.9, 137.8, 125.0, 120.0, 64.2, 52.5. 
 









The synthesis is based on a modified procedure from C. Uttamapinant et al.[47] 
6-hydroxymethyl-nicotinic acid methyl ester (1.00 g, 5.98 mmol) was dissolved in dry DCM 
(40 mL). Triethylamine (1.67 mL, 1.21 g, 12.0 mmol, 2.0 eq.) was added and the reaction was 
cooled to 0 °C. Subsequently, mesyl chloride (695 µL, 1.03 g, 8.97 mmol, 1.5 eq.) was added 
and the reaction was stirred over night at room temperature. The solvent was removed in vacuo 
and water was added (30 mL). The aqueous layer was extracted with DCM (3 × 30 mL), the 
combined organic layers were dried over MgSO4 and reconcentrated in vacuo. The residue was 
dissolved again in 60 mL THF and sodium azide (3.89 g, 59.8 mmol, 10.0 eq.) was added. The 
reaction was further stirred at room temperature for 48 h before being diluted with water and 
ethyl acetate (100 mL). The aqueous layer was extracted with ethyl acetate (3 × 100 mL) and 
the combined organic layers were dried over MgSO4 and filtered. The solvent was removed in 
vacuo to provide methyl 5-(azidomethyl)nicotinate as a pale yellow solid (705 mg, 3.67 mmol, 
62 %).     
Rf (iHex/EtOAc, 1/1) = 0.8. 
1H-NMR (400 MHz, CDCl3): δ (ppm): 9.19 (d, J = 2.1 Hz, 1H), 8.33 (dd, J = 8.1, 2.1 Hz, 1H), 
7.46 (d, J = 8.1 Hz, 1H), 4.58 (s, 2H), 3.96 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 165.2, 160.6, 150.5, 138.2, 125.2, 121.3, 55.6, 52.4. 









Methyl 5-(azidomethyl)nicotinate (703 mg, 3.66 mmol) was dissolved in methanol (15 mL) 
and 2.0 M LiOH solution in water was added (6.5 mL). The reaction was stirred for 1 hour at 
room temperature and subsequently quenched with HCl (2.0 M in water, 6.5 mL). The solvent 
was removed in vacuo and the residue was extracted with DCM (2 × 20 mL) and EtOAc (2 × 
20 mL). The combined organic layers were dried over MgSO4, filtered and the solvent was 
removed in vacuo. 6-azidomethylnicotinic acid 16 was obtained as a dark yellow solid (621 
mg, 3.49 mmol, 95 %). 
Rf (EtOAc) = 0.4. 
1H-NMR (400 MHz, CDCl3): δ (ppm): 9.31 (m, 1H), 8.47 (dd, J = 8.1, 2.1 Hz, 1H), 7.68 (d, J 
= 8.1 Hz, 1H), 4.81 (s, 2H). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 168.9, 160.9, 150.6, 139.4, 125.5, 122.8, 54.9. 
HR-MS (ESI): calc. for C7H7O2N4
+ [M+H]+: 179.0564; found: 179.0559. 
 
 




6-Azidomethylnicotinic acid 16 (20.3 mg, 114 µmol) and HATU (52.0 mg, 137 µmol, 1.2 eq.) 
were dissolved in dry DMF (0.4 mL) and DIPEA (40.0 µL, 29.5 mg, 228µmol, 2.0 eq.) were 
added. The mixture was stirred for 15 minutes at room temperature and O-(2-Aminoethyl)-O′-





(2-azidoethyl)nonaethylene glycol (60.0 mg, 114 µmol, 1.0 eq.) was added. The reaction was 
stirred over night at room temperature and the solvent was removed in vacuo. The residue was 
taken up in DCM (15 mL) and washed with brine (15 mL). The aqueous layer was reextracted 
one time with DCM (15 mL) and the combined organic layers were dried over MgSO4 and 
filtered. The solvent was removed in vacuo and the residue was purified by flash column 
chromatography (Silica, DCM/MeOH, 100/0 → 95/5). 17 was obtained as a colourless oil (63 
mg, 92 µmol, 81 %). 
Rf (DCM/MeOH, 10/1) = 0.6. 
1H-NMR (400 MHz, CDCl3): δ (ppm): 9.01 (d, J = 2.3 Hz, 1H, CHarom), 8.20 (dd, J = 8.1, 2.3 
Hz, 1H, CHarom), 7.42 (d, J = 8.1 Hz, 1H, CHarom), 4.53 (s, 2H, CaromCH2N3), 3.78 – 3.46 (m, 
42H, 21×ClinkerH2), 3.37 (t, J = 5.1 Hz, 2H, CH2CH2N3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 165.2 (C=O), 158.4 (Carom), 148.3 (Carom), 136.4 
(CHarom), 129.5 (CHarom), 121.5 (CHarom), 70.7 (ClinkerH2), 70.7 (ClinkerH2), 70.6 (ClinkerH2), 70.6 
(ClinkerH2), 70.5 (ClinkerH2), 70.3 (ClinkerH2), 70.0 (ClinkerH2), 69.6 (ClinkerH2), 55.3 (CaromCH2N3), 
50.7 (CH2CH2N3), 40.0 (CH2CH2NH). 
HR-MS (ESI): calc. for C29H51O11N8
+ [M+H]+: 687.3673; found: 687.3682. 










6-Azidomethylnicotinic acid 16 (947 mg, 5.32 mmol, 1.0 eq.) and HATU (2.20 g, 5.80 mmol, 
1.2 eq.) were dissolved in dry DMF (5.0 mL) and DIPEA (1.68 mL, 1.25 g, 9.66 mmol, 2.0 
eq.) was added. The mixture was stirred for 30 minutes at room temperature and tert-Butyl 2-
(2-(2-aminoethoxy)ethoxy)ethylcarbamate (1.14 mL, 1.20 g, 4.83 mmol, 0.9 eq.) was added. 
The reaction was stirred overnight at room temperature and the solvent was removed in vacuo. 
The residue was taken up in DCM (50 mL) and washed with brine (50 mL). The combined 
organic layers were dried over MgSO4, filtered and the solvent was removed in vacuo. The 
residue was purified by flash column chromatography (Silica, DCM/MeOH, 100/0 → 96/4). 
Tert-butyl (2-(2-(2-(6-(azidomethyl)nicotinamido)ethoxy)ethoxy)ethyl)carbamate was 
obtained as a brown oil (1.78 g, 4.36 mmol, 91 %). 
Rf (DCM/MeOH, 10/1) = 0.8. 
1H-NMR (400 MHz, CDCl3): δ (ppm): 8.97 (d, J = 2.3 Hz, 1H, CHarom), 8.15 (dd, 1H, J = 8.1, 
2.3 Hz, 1H, CHarom), 7.40 (d, J = 7.9 Hz, 1H, CHarom), 4.50 (s, 2H, CaromCH2N3), 3.77 – 3.55 
(m, 10H, 5×ClinkerH2), 3.28 – 3.22 (m, 2H, ClinkerH2), 1.37 (s, 9H, 3×CH3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 165.4 (C=O), 158.5 (C=O), 156.1 (Carom), 148.2 
(Carom), 136.3 (CHarom), 129.4 (CHarom), 121.6 (CHarom), 79.4 (Ctert), 70.2 (OCH2CH2O), 70.1 
(OCH2CH2O), 69.5 (OCH2CH2NHBoc), 55.6 (CaromCH2N3), 40.3 (OCH2CH2NHBoc), 39.8 
(OCH2CH2NHCO), 28.4 (C(CH3)3). 
HR-MS (ESI): calc. for C18H29O5N6
+ [M+H]+: 409.2194; found: 409.2191. 
 









Tert-butyl (2-(2-(2-(6-(azidomethyl)nicotinamido)ethoxy)ethoxy)ethyl)carbamate (1.78 g, 
4.36 mmol, 1.0 eq.) was dissolved in methanol (6mL) and an aqueous solution of HCl was 
added (2.0 M, 3.0 mL, 20.0 eq.). The reaction was stirred at 50 °C for 2 hours before being 
quenched by addition of a solution of NaOH (1.0 M in water, 6 mL). The solvent was removed 
in vacuo and the aqueous layer was extracted with DCM (2 × 15 mL) and EtOAc (1 × 15 mL). 
The organic layers were combined, dried over MgSO4 and filtered. The solvent was removed 
in vacuo and 21 was obtained as an orange oil (955 mg, 3.10 mmol, 72 %). 
Rf (DCM/MeOH, 10/1) = 0.3. 
1H-NMR (599 MHz, CDCl3): δ (ppm): 9.01 (d, J = 2.3 Hz, 1H, CHarom), 8.19 (dd, 1H, J = 8.1, 
2.3 Hz, 1H, CHarom), 7.42 (d, J = 8.1 Hz, 1H, CHarom), 4.53 (s, 2H, CaromCH2N3), 3.72 – 2.75 
(m, 12H, 6×ClinkerH2). 
13C-NMR (151 MHz, CDCl3): δ (ppm): 165.3 (C=O), 158.5 (Carom), 148.2 (Carom), 136.3 
(CHarom), 129.5 (CHarom), 121.5 (CHarom), 73.0 (OCH2CH2NH2), 70.3 (OCH2CH2O), 70.0 
(OCH2CH2O), 69.7 (OCH2CH2NHCO), 55.3 (CaromCH2N3), 41.5 ((OCH2CH2NH2), 39.9 
(OCH2CH2NHCO). 
HR-MS (ESI): calc. for C13H21O3N6
+ [M+H]+: 309.1673; found: 309.1673. 
 









Tetraethylenglycole 22 (29.25 g, 150.6 mmol, 1.0 eq.) was dissolved in dry THF (100 mL) and 
triethylamine (122 g, 1.20 mol, 8.0 eq.) was added. The reaction was cooled down to 0 °C and 
a solution of tosylchloride (28.71 g, 150.6 mmol, 1.0 eq.) in dry THF (50 mL) was added over 
a period of 1 hour. After 48-hour stirring at room temperature the solvent was removed in 
vacuo. The mixture was taken up in HCl (2 M, 150 mL) and extracted with DCM (4 × 150 mL). 
The combined organic layers were dried over MgSO4 and filtered. After removal of the solvent  
in vacuo the crude product was purified by flash column chromatography (Silica, DCM → 
DCM/MeOH (99 /1 → 0/1)). The product 25 was obtained as a colourless oil (48.27 g, 138.6 
mmol, 92 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 7.82-7.76 (m, 2H, CHarom.), 7.37-7.30 (m, 2H, CHarom.), 
4.20-4.12 (m, 2H, CH2), 3.73-3.52 (m, 14H, 7×CH2), 2.42 (s, 3H, CH3), 2.38-2.31 (s, 1H, OH). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 144.9 (Carom.), 133.2 (Carom.), 130.0 (2×CHarom.), 128.1 
(2×CHarom.), 72.6 (CH2), 70.9 (CH2), 70.8 (CH2), 70.6 (CH2), 70.5 (CH2), 69.4 (CH2), 68.9 
(CH2), 61.9 (CH2), 21.8 (CH3).  
HR-MS (ESI): C15H25O7S







To 25 (8.08 g, 23.19 mmol, 1.0 eq.) in solution in dry DMF (100 mL) was added NaN3 (7.54 
g, 116 mmol, 5.0 eq.). The mixture was stirred at 70 °C for 8 hours and the solvent was removed 
in vacuo. The residue was retaken in water (100 mL), extracted with DCM (2 × 100 mL) and 





the combined organic layers were dried over MgSO4 and filtered. The solvent was removed in 
vacuo and 2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethan-1-ol  26 was obtained as a colourless 
oil (4.87 g, 22.2 mmol, 96 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 3.76 – 3.68 (m, 2H, CH2), 3.68 – 3.62 (m, 10H, 5×CH2), 
3.63 – 3.58 (m, 2H, CH2), 3.39 (t, J = 5.2 Hz, 2H, CH2).  
13C-NMR (101 MHz, CDCl3): δ (ppm): 72.5 (CH2), 70.7 (CH2), 70.7 (CH2), 70.6 (CH2), 70.4 
(CH2), 70.1 (CH2), 61.7 (CH2), 50.7 (CH2). 
HR-MS (ESI): C8H18O4N3
+ [M+H]+, calc.: 220.1292, found: 220.1293. 
 
 




26 (4.75 g, 21.67 mmol) was dissolved in dry DCM (50 mL). Triethylamine (8.92 mL, 6.51 g, 
65.0 mmol, 3.0 eq.) was added and the reaction was cooled to 0 °C. Subsequently tosylchloride 
(12.39 g, 65.00 mmol, 3.0 eq.) was added and the reaction was stirred over night at room 
temperature. The solvent was removed in vacuo and the residue was taken up in HCl (2.0 M in 
water, 50 mL). After extraction with DCM (5 × 50 mL), the combined organic layers were 
dried over MgSO4, filtered and the solvent was remved in vacuo. The crude product was 
purified by flash column chromatography (Silica, i-Hex/EtOAc 1/0 → 3/7). 2-(2-(2-(2-
azidoethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate 23 was obtained as a colourless 
oil (7.42 g, 20.0 mmol, 92 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 7.80 (d, J = 7.9 Hz, 2H, CHarom), 7.34 (d, J = 7.9 Hz, 
2H, CHarom), 4.16 (t, J = 4.9 Hz, 2H, CH2), 3.72 – 3.58 (m, 12H, 6×CH2), 3.38 (t, J = 5.0 Hz, 
2H, CH2), 2.45 (s, 3H, CH3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 144.9 (Carom.), 133.2 (Carom.), 130.0 (2×CHarom.), 128.1 
(2×CHarom.), 70.9 (CH2), 70.8 (CH2), 70.8 (CH2), 70.2 (CH2), 69.4 (CH2), 68.9 (CH2), 50.8 
(CH2), 21.8 (CH3).  
HR-MS (ESI): C15H27O6N4S
+ [M+NH4]
+, calc.: 391.1646, found: 391.1649. 
 









To a solution of methyl 3,5-dihydroxybenzoate (30 mg, 178.41 µmol, 1.0 eq.) 20 in acetone 
(1.7 mL), 23 (147 mg, 392.51 µmol, 2.2 eq.) and K2CO3 (123.29 mg, 892.07 µmol, 5.0 eq.) 
were added. The reaction was stirred at 55 °C for 30 hours and the solvent was removed. The 
residue was taken up in water (5 mL) and DCM (5 mL) and extracted with DCM (3 × 5 mL). 
The combined organic layers were dried over MgSO4, filtered and the solvent removed in 
vacuo. The crude product was purified by flash column chromatography (Silica, DCM/MeOH 
100/0 → 96/4) and the product was obtained as a yellow oil (78.0 mg, 137 µmol, 77 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 7.19 – 7.05 (m, 2H, 2×CHarom), 7.12 – 7.05 (m, 1H, 
CHarom), 4.17 – 4.05 (m, 4H, 2×CH2), 3.90 – 3.79 (m, 7H, 2×CH2+CH3), 3.75 – 3.56 (m, 20H, 
10×CH2), 3.36 (t, J = 5.0 Hz, 4H, 2×CH2). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 166.8 (C=O), 159.7 (2×Carom.), 131.8 (Carom.), 108.0 
(2×CHarom), 106.9 (CHarom), 70.8 (CH2), 70.7 (CH2), 70.7 (CH2), 70.6 (CH2), 70.0 (CH2), 70.0 
(CH2), 69.6 (CH2), 69.6 (CH2), 67.7 (CH2), 67.7 (CH2), 52.2 (CH3), 50.7 (CH2N3). 
HR-MS (ESI): C24H42O10N7
+ [M+NH4]
+, calc.: 588.2987, found: 588.2976. 
 
 









Methyl 3,5-bis(2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethoxy)benzoate (56 mg, 98.14 µmol, 
1.0 eq.) was dissolved in methanol (2 mL) and NaOH (1.0 M in water, 491 µL, 5.0 eq.) was 
added. The reaction was stirred at 40 °C for 3 hours and cooled to room temperature. It was 
subsequently quenched by adding dropwise HCl (2.0 M, 250 µL) and the solvent was removed 
in vacuo. The residue was taken up in water (10 mL) and extracted with EtOAc (3 × 10 mL). 
The combined organic layers were dried over MgSO4, filtered and 24 was obtained as a 
colourless liquid (50 mg, 90 µmol, 92 %). 
 
1H-NMR (400 MHz, CDCl3): δ (ppm): 7.23 – 7.18 (m, 2H, 2×CHarom), 6.73 – 6.67 (m, 1H, 
CHarom), 4.18 – 4.05 (m, 4H, 2×CH2), 3.90 – 3.62 (m, 24H, 12×CH2), 3.37 (t, J = 5.0 Hz, 4H, 
2×CH2) . 
13C-NMR (101 MHz, CDCl3): δ (ppm): 170.5 (C=O), 159.8 (2×Carom.), 131.2 (Carom.), 108.4 
(2×CHarom), 107.5 (CHarom), 70.8 (CH2), 70.7 (CH2), 70.7 (CH2), 70.6 (CH2), 70.0 (CH2), 69.6 
(CH2), 67.7 (CH2), 50.7 (CH2N3). 
HR-MS (ESI): C23H40O10N7
+ [M+NH4]
+, calc.: 574.2831, found: 574.2821. 
 








24 (25 mg, 44.92 µmol, 1.0 eq.) was dissolved in dry DMF (0.5 mL). HATU (21 mg, 54 µmol, 
1.2 eq.) and DIPEA (15.7µL, 11.6 mg, 89.8 µmol, 2 eq.) were added and the mixture was 
stirred 45 minutes at room temperature. A solution of 21 (15 mg, 49.4 µmol, 1.1 eq.)  in DMF 
(0.5 mL) was added and the reaction was stirred 12 hours at room temperature. The solvent 
was removed in vacuo and the residue was taken up in DCM (10 mL) and washed with brine 
(10 mL). The aqueous layer was reextracted one time with DCM (15 mL) and the combined 
organic layers were dried over MgSO4 and filtered. The solvent was removed in vacuo and the 
residue was purified by flash column chromatography (Silica, DCM/MeOH, 100/0 → 95/5). 
19 was obtained as an orange oil (31 mg, 37 µmol, 82 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 8.98 (d, J = 2.1 Hz, 1H, CHaromNarom), 8.15 (dd, J = 8.1, 
2.1 Hz, 1H, CHarom), 7.40 (d, J = 8.0 Hz, 1H, CHarom), 7.14 – 7.04 (m, 1H, CHarom), 6.91 (d, J 
= 2.3 Hz, 2H), 4.53 (s, 2H, CaromCH2N3), 4.26 – 3.20 (m, 40H, 20×CH2), 1.58 – 1.16 (m, 4H, 
2×CH2). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 167.3 (C=O), 165.2 (C=O), 159.8 (2×Carom), 158.4 
(CaromHNarom), 147.8 (CHaromNarom), 136.6 (CHarom), 129.5 (Carom), 121.7 (CHarom), 106.0 
(CHarom), 104.3 (CHarom), 77.4 (CH2), 77.0 (CH2), 76.7 (CH2), 70.7 (CH2), 70.7 (CH2), 70.6 
(CH2), 70.3 (CH2), 70.2 (CH2), 70.0 (CH2), 69.7 (CH2), 69.6 (CH2), 69.5 (CH2), 67.6 (CH2), 
55.1 (CaromCH2N3), 50.7 (CH2CH2N3), 39.8 (OCH2CH2NH), 39.7 (OCH2CH2NH). 
HR-MS (ESI): C36H55O12N12
+ [M+H]+, calc.: 847.4057, found: 847.4056. 





4.2.3 Synthesis of the picolyl azide-PEG11-TMS protected alkyne linker (34) 




5-(Trimethylsilyl)pent-4-yn-1-ol 29 (4.97 g, 31.8 mmol) was dissolved in dry DMF (40 mL). 
PDC (29.91 g, 79.49 mmol, 2.5 eq.) was added and the reaction was stirred 24 hours at room 
temperature. The residue was diluted with water (180 mL) and extracted with diethyl ether 
(3×100 mL). The combined organic layers were washed with HCl (1 M in water, 2×100 mL), 
brine (100 mL), dried over MgSO4 and filtered. The solvent was removed in vacuo and the 
crude product was purified by flash column chromatography (Silica, i-Hex/EtOAc 1/0 → 2:3). 
5-(Trimethylsilyl)pent-4-ynoic acid 30 was obtained as a white oil (2.2 g, 12.9 mmol, 41 %). 
 
1H-NMR (400 MHz, CDCl3): δ (ppm): 2.68 – 2.48 (m, 4H, CH2), 0.14 (s, 9H, Si(CH3)3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 176.7 (C=O), 104.9 (CH2C≡C), 85.4 (CH2C≡C), 33.4 
(CH2CH2C≡C), 15.6 (CH2C≡C), 0.0 (Si(CH3)3). 









5-(Trimethylsilyl)pent-4-ynoic acid 30 (434 mg, 2.55 mmol, 1.0 eq.) was dissolved in DCM 
(10 mL) and DCC (263 mg, 1.27 mmol, 0.5 eq.) was added. The reaction was stirred over night 
at room temperature and was filtered. The filtrate was stored at -20 °C for 2 hours and filtered 
again. This step was repeated two times and the solvent was removed in vacuo to provide 5-
(Trimethylsilyl)pent-4-ynoic anhydride 28 as a colourless oil (335 mg, 1.04 mmol, 42 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 2.99 – 2.24 (m, 8H, 2×CH2), 0.14 (s, 18H, 2×Si(CH3)3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 167.3 (2×C=O), 103.8 (2×CH2C≡C), 86.2 
(2×CH2C≡C), 34.6 (2×CH2CH2C≡C), 15.2 (2×CH2C≡C), 0.0 (2×Si(CH3)3). 
HR-MS (ESI): C16H30O3NSi2 [M+NH4]








6-Azidomethylnicotinic acid 16 (50.0 mg, 281 µmol, 1.0 eq.) was dissolved in dry DMF (500 
µL). HATU (128 mg, 337µmol, 1.2 eq.) and DIPEA (97.8 µL, 72.6 mg, 561 µmol, 2.0 eq.) 
were added and the reaction mixture was stirred 10 minutes at room temperature. O-(2-
Aminoethyl)-O′-(2-(Boc-amino)ethyl)decaethylene glycol (180.97 mg, 280.66 µmol, 1.0 eq.) 





in solution in dry DMF (500 µL) was added. The reaction was stirred over night and the solvent 
was removed in vacuo. The residue was taken up in DCM (5 mL), washed with brine and dried 
over MgSO4 and filtered. The crude product was concentrated in vacuo and purified by flash 
column chromatography (Silica, DCM/MeOH, 100/0 → 96/4). Tert-butyl(1-(6-
(azidomethyl)pyridin-3-yl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-
azaheptatriacontan-37-yl)carbamate was obtained as a brown oil (213 mg, 265 µmol, 95 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 9.02 (d, J = 2.2 Hz, 1H, CaromHNarom), 8.21 (dd, J = 8.1, 
2.2 Hz, 1H, CHarom), 7.42 (d, J = 8.1 Hz, 1H, CHarom), 4.53 (s, 2H, CaromCH2N3), 3.71 – 3.56 
(m, 44H, 22×ClinkerH2), 3.51 (t, J = 5.2 Hz, 2H, ClinkerH2), 3.29 (q, J = 5.4 Hz, 2H, ClinkerH2), 
1.42 (s, 9H, 3×CH3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 165.2 (C=O), 158.3 (Carom), 156.0 (C=O), 148.3 
(CaromHNarom), 136.5 (CaromH), 129.5 (Carom), 121.5 (CaromH), 79.1 (Ctert), 70.6 (CH2), 70.5 
(CH2), 70.5 (CH2), 70.5 (CH2), 70.5 (CH2), 70.3 (CH2), 70.2 (CH2), 69.7 (CH2), 55.2 
(CaromCH2N3), 40.3 (OCH2CH2NHCO), 40.0 (OCH2CH2NHCO), 28.4 (C(CH3)3). 
HR-MS (ESI): C36H65O14N6 [M+H]









2-azaheptatriacontan-37-yl)carbamate (100 mg, 124.23 µmol, 1.0 eq.) was dissolved in HCl 
(4.0 M in dioxane, 500 µL, 73 mg, 16.1 eq.) and stirred at 0 °C for 2 hours. The solvent was 
removed in vacuo and N-(35-amino-3,6,9,12,15,18,21,24,27,30,33-
undecaoxapentatriacontyl)-6-(azidomethyl)nicotinamide 33 was obtained as a yellow oil (92.0 
mg,  124 µmol, quant.). 





1H-NMR (400 MHz, CDCl3): δ (ppm): 8.98 (d, J = 1.8 Hz, 1H, CaromHNarom), 8.82 (dd, J = 8.4, 
1.8 Hz, 1H, CHarom), 7.53 (d, J = 8.3 Hz, 1H, CHarom), 4.71 (s, 2H, CaromCH2N3), 3.38 – 2.97 
(m, 46H, 23×ClinkerH2), 2.75 – 2.63 (m, 2H, ClinkerH2). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 161.6 (C=O), 152.5 (Carom), 145.5 (CaromHNarom), 141.5 
(CaromH), 133.0 (Carom), 125.2 (CaromH), 70.5 (CH2), 70.4 (CH2), 70.3 (CH2), 70.3 (CH2), 70.2 
(CH2), 70.2 (CH2), 70.2 (CH2), 70.1 (CH2), 70.0 (CH2), 70.0 (CH2), 70.0 (CH2), 69.9 (CH2), 
69.2 (CH2), 66.9 (CH2), 49.9 (CaromCH2N3), 40.2 (OCH2CH2NH2), 40.1 (OCH2CH2NHCO). 
HR-MS (ESI): C31H57O12N6 [M+H]









(azidomethyl)nicotinamide 33 (40 mg, 51 µmol, 1.0 eq.) was dissolved in dry DCM (1 mL). 
Pyridine (83 µL, 81 mg, 1.0 mmol, 20.0 eq.) and DMAP (6 mg, 51.4 µmol, 1.0 eq) were added 
and the reaction mixture was cooled to 0 °C. A solution of 5-(Trimethylsilyl)pent-4-ynoic 
anhydride (50 mg, 154.3 µmol, 3.0 eq.) in DCM (1 mL) was added dropwise and the reaction 
was stirred over night while being allowed to warm to room temperature. Subsequently, the 
residue was dissolved in DCM (20 mL) and washed with water (20 mL), NaHCO3 saturated 
aqueous solution (20 mL) and CuSO4 saturated aqueous solution (20 mL). The organic layer 
was dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified by 
flash column chromatography (Silica, DCM/MeOH, 100/0 → 85/15) and the product 34 was 
obtained as a yellow oil (43 mg, 50 µmol, 98 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 9.05 (s, 1H, CaromHNarom), 8.23 (dd, J = 8.0, 1.8 Hz, 
1H, CHarom), 7.41 (d, J = 6.9 Hz, 1H, CHarom), 4.52 (s, 2H, CaromCH2N3), 3.68 – 3.50 (m, 46H, 





23×ClinkerH2), 3.46 – 3.40 (m, 2H, ClinkerH2), 2.57 – 2.49 (m, 2H, CH2CH2C≡C), 2.43 – 2.34 
(m, 2H, CH2CH2C≡C), 0.11 (s, 9H, Si(CH3)3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 171.2 (C=O), 165.3 (C=O), 158.2 (Carom), 148.4 
(CaromHNarom), 140.4 (Carom), 136.4 (CaromH), 121.4 (CaromH), 105.9 (CH2C≡C), 85.3 
(CH2C≡C), 70.5 (CH2), 70.5 (CH2), 70.5 (CH2), 70.5 (CH2), 70.5 (CH2), 70.5 (CH2), 70.4 
(CH2), 70.4 (CH2), 70.2 (CH2), 70.2 (CH2), 69.9 (CH2), 69.8 (CH2), 55.3 (CaromCH2N3), 40.0 
(OCH2CH2NHCO), 39.3 (OCH2CH2NHCO), 35.4 (CH2CH2C≡C), 16.3 (CH2CH2C≡C), 0.1 
(Si(CH3)3).  
HR-MS (ESI): C39H72O13N7Si [M+NH4]




4.2.4 Synthesis of the picolyl azide-PEG11-TES protected alkyne linker (37) 




5-Triethylsilyl-4-pentyn-1-ol 35 (4.55 g, 22.9 mmol, 1.0 eq.) was dissolved in dry DMF (50 
mL). PDC (21.57 g, 57.34 mmol, 2.5 eq.) was added and the reaction was stirred overnight at 
room temperature. Diethyl ether was added and the reaction mixture was filtered over celite. 
The residue was concentrated in vacuo and purified by flash column chromatography (Silica, 
i-Hex/EtOAc 1/0 → 1/1). 5-(triethylsilyl)pent-4-ynoic acid 36 was obtained as colourless oil 
(1.74 g, 8.19 mmol, 36 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 2.66 – 2.51 (m, 4H, 2×CH2), 0.97 (t, J = 7.9 Hz, 9H, 
Si(CH2CH3)3), 0.56 (q, J = 7.8 Hz, 6H, Si(CH2CH3)3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 178.0 (C=O), 105.6 (CH2C≡C), 82.9 (CH2C≡C), 33.6 
(CH2CH2C≡C), 15.6 (CH2CH2C≡C), 7.4 (Si(CH2CH3)3), 4.4 (Si(CH2CH3)3). 
HR-MS (ESI): C11H19O2Si [M-H]
-, calc.: 211.1160, found: 211.1160. 










5-(triethylsilyl)pent-4-ynoic acid 36 (6.63 mg, 31.2 µmol, 1.1 eq.) was dissolved in dry DMF 
(300 µL). DIPEA (9.9 µL, 7.3 mg, 57 µmol, 2.0 eq.) and HATU (12.95 mg, 34.05 µmol, 1.2 
eq.) were added and the reaction mixture was stirred 30 minutes at room temperature. A 
solution of N-(35-amino-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontyl)-6-
(azidomethyl)nicotinamide 33 (20 mg, 28 µmol in DMF (300 µL) was added and the reaction 
was stirred overnight at room temperature. The solvent was removed in vacuo and the residue 
was taken up in DCM (10 mL) and washed with brine (10 mL). The organic layer was dried 
over MgSO4, filtered, concentrated in vacuo and purified by flash column chromatography 
(Silica, DCM/MeOH, 100/0 → 90/10). The product 37 was obtained as a pale yellow oil (22 
mg, 24 µmol, 87 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 9.03 (dd, J = 2.3, 0.8 Hz, 1H, CaromHNarom), 8.22 (dd, 
J = 8.1, 2.3 Hz, 1H, CHarom), 7.41 (d, J = 8.1 Hz, 1H, CHarom), 4.52 (s, 2H, CaromCH2N3), 3.71 
– 3.54 (m, 44H, 22×ClinkerH2), 3.52 (dd, J = 5.6, 4.5 Hz, 2H, ClinkerH2), 3.46 – 3.38 (m, 2H, 
ClinkerH2), 2.59 – 2.34 (m, 4H, 2×CH2), 0.94 (t, J = 7.9 Hz, 9H, Si(CH2CH3)3), 0.53 (q, J = 7.9 
Hz, 6H, Si(CH2CH3)3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 171.2 (C=O), 165.3 (C=O), 158.2 (Carom), 148.4 
(CaromHNarom), 136.5 (CaromH), 129.5 (Carom), 121.5 (CaromH), 106.9 (CH2C≡C), 82.4 
(CH2C≡C), 70.5 (CH2), 70.5 (CH2), 70.5 (CH2), 70.5 (CH2), 70.4 (CH2), 70.4 (CH2), 70.2 
(CH2), 70.2 (CH2), 69.9 (CH2), 69.8 (CH2), 55.2 (CaromCH2N3), 39.9 (OCH2CH2NHCO), 39.2 
(OCH2CH2NHCO), 35.7 (CH2CH2C≡C), 16.3 (CH2CH2C≡C), 7.5 (Si(CH2CH3)3), 4.4 
(Si(CH2CH3)3). 
HR-MS (ESI): C42H75O13N6Si [M+H]
+, calc.: 899.5156, found: 899.5135. 
 











11-Azido-3,6,9-trioxaundecanyl-(4'-methylbenzolsulfonat) 23 (7.42 g, 19.87 mmol, 1.0 eq.) 
was dissolved in dry methanol (15 mL) and 10% Pd/C (1.47 g, 3.97 mmol, 20 mol%) was 
added. The mixture was cooled to 0 °C and Boc2O (11.71 g, 53.7 mmol, 2.7 eq.) was added. 
The reaction was stirred under H2-atmosphere (1 bar) for 4 hours. The residue was filtered over 
celite, concentrated in vacuo and purified by flash column chromatography (Silica, i-Hex → i-
Hex/EtOAc 1/1). The product 38 was obtained as a yellow oil (6.06 g, 13.5 mmol, 68 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 7.78 (d, J = 7.9 Hz, 2H, 2×CHarom), 7.33 (d, J = 7.9 Hz, 
2H, 2×CHarom), 4.99 (s, 1H, NH), 4.20 – 4.11 (m, 2H, CH2), 3.70 – 3.65 (m, 2H, CH2), 3.61 – 
3.57 (m, 8H, 4×CH2), 3.51 (t, J = 5.2 Hz, 2H, CH2), 3.33 – 3.24 (m, 2H, CH2), 2.44 (s, 3H, 
CH3), 1.43 (d, J = 3.0 Hz, 9H, 3×CH3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 156.0 (C=O), 144.8 (Carom), 133.0 (Carom), 129.8 
(CHarom), 128.0 (CHarom), 79.2 (Ctert), 70.8 (CH2), 70.6 (CH2), 70.5 (CH2), 70.2 (CH2), 70.2 
(CH2), 69.2 (CH2), 68.7 (CH2), 40.3 (OCH2CH2NHCO), 28.4 (C(CH3)3), 21.7 (CH3). 
HR-MS (ESI): C20H34O8NS [M+H]
+, calc.: 448.2000, found: 448.2012. 










Methyl-3,5-dihydroxybenzoate 20 (32 mg, 190µmol) and 2-(2-(2-(2-
((tertButoxycarbonyl)amino)ethoxy)ethoxy)ethoxy)ethyl-(4'-methylbenzol-sulfonat) 38 (187 
mg, 419µmol, 2.2 eq.) were dissolved in acetone (2 mL). K2CO3 (184 mg, 1.33 mmol, 7.0 eq.) 
was added and the reaction was stirred at 60 °C for 20 hours. The solvent was removed in 
vacuo and the residue was taken up in DCM (10 mL) and water (10 mL). It was subsequently 
extracted with DCM (3×20 mL) and the combined organic layers were dried over MgSO4 and 
filtered. The solvent was removed in vacuo and the crude product was purified by flash column 
chromatography (Silica, i-Hex → EtOAc). The product was obtained as a colourless oil (95 
mg, 132 mmol, 70 %).  
1H-NMR (400 MHz, CDCl3): δ (ppm): 7.18 (d, J = 2.3 Hz, 2H, 2×CHarom), 6.68 (t, J = 2.4 Hz, 
1H, CHarom), 5.04 (s, 2H, 2×NH), 4.13 (t, J = 4.8 Hz, 4H, 2×CH2), 3.88 (s, 3H, COOCH3), 3.87 
– 3.83 (m, 4H, 2×CH2), 3.77 – 3.58 (m, 16H, 8×CH2), 3.52 (t, J = 5.2 Hz, 4H, 2×CH2), 3.30 
(q, J = 5.4, 4.9 Hz, 4H, 2×CH2), 1.42 (s, 18H, 6×CH3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 166.8 (C=O), 159.7 (2×NHC=O), 156.0 (2×Carom), 
131.9 (Carom), 108.0 (2×CHarom), 106.9 (CHarom), 79.2 (2×Ctert), 70.9 (CH2), 70.6 (CH2), 70.6 





(CH2), 70.2 (CH2), 70.2 (CH2), 69.6 (CH2), 67.7 (CH2), 52.3 (CH3), 40.4 (OCH2CH2NHCO), 
28.4 (2×C(CH3)3). 
HR-MS (ESI): C34H62O14N3 [M+NH4]









(142 mg, 198µmol, 1.0 eq.) was dissolved in methanol (1 mL) and LiOH solution was added 
(2.0 M in water, 494 µL, 5.0 eq.). The reaction was stirred 12 hours at 50 °C and quenched with 
HCl solution (2.0 M in water, 0.5 mL). The residue was concentrated in vacuo, taken up in 
water (10 mL) and extracted with DCM (2×10 mL) and EtOAc (2×10 mL). The combined 
organic layers were dried over MgSO4, filtered and the solvent was removed in vacuo to 
provide the product 39 as a transparent oil (139 mg, 198 µmol, quant.). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 7.24 – 7.20 (m, 2H, 2×CHarom), 6.69 (d, J = 2.4 Hz, 1H, 
CHarom), 5.09 (s, 2H, 2×NH), 4.19 – 4.07 (m, 4H, 2×CH2), 3.84 (d, J = 5.0 Hz, 4H, 2×CH2), 
3.78 – 3.58 (m, 16H, 8×CH2), 3.53 (t, J = 5.2 Hz, 4H, 2×CH2), 3.30 (q, J = 5.4 Hz, 4H, 2×CH2), 
1.42 (s, 18H, 6×CH3). 





13C-NMR (101 MHz, CDCl3): δ (ppm): 170.0 (C=O), 159.8 (2×NHC=O), 156.1 (2×Carom), 
131.5 (Carom), 108.5 (2×CHarom), 107.4 (CHarom), 79.3 (2×Ctert), 70.9 (CH2), 70.6 (CH2), 70.6 
(CH2), 70.2 (CH2), 69.6 (CH2), 67.7 (CH2), 40.3 (OCH2CH2NHCO), 28.4 (2×C(CH3)3). 
HR-MS (ESI): C33H60O14N3 [M+NH4]









39 (90 mg, 128 µmol, 1.0 eq.) was dissolved in dry DMF (1 mL) and DIPEA (44.5 µL, 33 mg, 
255 µmol, 2.0 eq.) and HATU (58 mg, 153 µmol, 1.2 eq.) were added. The reaction mixture 
was stirred 30 minutes at room temperature and 21 (43 mg, 140 µmol, 1.1 eq.) was added. The 
reaction was stirred overnight and the solvent was removed in vacuo. The residue was taken 
up in DCM (10 mL) and washed with brine (10 mL). The organic layer was dried over MgSO4, 
filtered, concentrated in vacuo and purified by flash column chromatography (Silica, EtOAc 
→ EtOAc/MeOH 98/2). The product was obtained as an orange oil (86 mg, 86 µmol, 68 %). 
1H-NMR (400 MHz, CDCl3): δ (ppm): 9.01 (d, J = 2.2 Hz, 1H, CHarom), 8.17 (dd, J = 8.1, 2.2 
Hz, 1H CHarom), 7.40 (d, J = 8.1 Hz, 1H, CHarom), 6.93 (d, J = 2.2 Hz, 2H, 2×CHarom), 6.55 (t, 
J = 2.3 Hz, 1H, CHarom), 5.11 (s, 2H, 2×NH), 4.53 (s, 2H, CaromCH2N3), 4.10 (t, J = 4.7 Hz, 4H, 





2×CH2), 3.83 (t, J = 4.7 Hz, 4H, 2×CH2), 3.75 – 3.58 (m, 30H, 15×CH2), 3.52 (t, J = 5.2 Hz, 
4H, 2×CH2), 3.28 (q, J = 5.4 Hz, 4H, 2×CH2), 1.42 (s, 18H, 6×CH3). 
13C-NMR (101 MHz, CDCl3): δ (ppm): 167.3 (C=O), 165.2 (C=O), 159.8 (2×Carom), 156.1 
(CaromHNarom), 147.9 (2×NHC=O), 136.7 (CaromH), 130.5 (Carom), 129.5 (Carom), 121.7 (CaromH), 
105.9 (2×CaromH), 104.3 (CaromH), 79.2 (2×Ctert), 70.8 (CH2), 70.6 (CH2), 70.6 (CH2), 70.3 
(CH2), 70.2 (CH2), 69.7 (CH2), 69.6 (CH2), 69.6 (CH2), 67.6 (CH2), 55.1 (CaromCH2N3), 40.4 
(OCH2CH2NHCO), 39.8 (OCH2CH2NHCO), 28.4 (2×C(CH3)3). 
HR-MS (ESI): C46H75O16N8 [M+H]
+, calc.: 995.5296, found: 995.5299. 











diyl))bis(oxy))bis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-diyl))dicarbamate (86 mg, 86 
µmol, 1.0 eq.) was dissolved in HCl solution (4.0 M in dioxane, 864 µL, 3.46 mmol, 40.0 eq.) 
and stirred at 0 °C for 4 hours. The solvent was removed in vacuo and 41 was obtained as a 
colourless oil (72 mg, 86 µmol, quant). 
1H-NMR (400 MHz, MeOD): δ (ppm): 9.10 – 9.07 (m, 1H, CHarom), 8.70 (dd, J=8.3, 2.1 Hz, 
1H, CHarom), 7.97 – 7.89 (m, 1H, CHarom), 7.02 – 6.92 (m, 2H, 2×CHarom), 6.63 (t, J=2.3 Hz, 
1H CHarom), 4.91 (s, 2H, CaromCH2N3), 4.14 (t, J = 4.7 Hz, 4H, 2×CH2), 3.85 (t, J = 4.7 Hz, 4H, 
2×CH2), 3.77 – 3.40 (m, 34H, 17×CH2), 3.28 (q, J = 5.4 Hz, 4H, 2×CH2), 3.10 (t, J = 5.0 Hz, 
4H, 2×CH2). 
13C-NMR (101 MHz, MeOD): δ (ppm): 168.3 (C=O), 163.4 (C=O), 160.0 (2×Carom), 155.0 
(CaromHNarom), 143.2 (CaromHNarom), 142.3 (Carom), 136.3 (CaromH), 131.7 (Carom), 124.6 
(CaromH), 105.7 (2×CaromH), 104.3 (CaromH), 75.4 (CH2), 75.3 (CH2), 75.1 (CH2), 73.0 (CH2), 
72.7 (CH2), 70.2 (CH2), 70.1 (CH2), 70.0 (CH2), 69.9 (CH2), 69.8 (CH2), 69.8 (CH2), 69.3 
(CH2), 69.0 (CH2), 68.8 (CH2), 67.6 (CH2), 67.5 (CH2), 66.7 (CH2), 66.5 (CH2), 66.4 (CH2), 
56.9 (CaromCH2N3), 39.8 (OCH2CH2NHCO), 39.3(OCH2CH2NH2). 
HR-MS (ESI): C36H59O12N8 [M+H]
+, calc.: 795.4248, found: 795.4245. 













5-(triethylsilyl)pent-4-ynoic acid 36 (12 mg, 57µmol, 3.0 eq.) was dissolved in dry DMF (200 
µL). DIPEA (13 µL, 9.8 mg, 76 µmol, 4.0 eq.) and HATU (17.22 mg, 45.29 µmol, 2.4 eq.) 
were added and the reaction mixture was stirred 30 minutes at room temperature. A solution 
of 41 (15 mg, 19 µmol, 1.0 eq.) in DMF (200 µL) was added and the reaction was stirred 
overnight at room temperature. The solvent was removed in vacuo and the residue was taken 
up in DCM (10 mL) and washed with brine (10 mL). The organic layer was dried over MgSO4, 
filtered, concentrated in vacuo and purified by flash column chromatography (Silica, DCM → 
DCM/MeOH 90:10). The product 40 was obtained as a clear yellow oil (22 mg, 19 µmol, 99 
%). 
1H-NMR (599 MHz, CDCl3): δ (ppm): 9.10 – 9.07 (m, 1H, CHarom), 8.31 (dd, J=8.3, 2.1 Hz, 
1H, CHarom), 8.03 – 7.95 (m, 1H, CHarom), 7.54 (d, J = 8.1 Hz, 1H, CHarom), 6.96 – 6.84 (m, 2H, 





2×CHarom), 6.51 (t, J=2.3 Hz, 1H CHarom), 4.63 (s, 2H, CaromCH2N3), 4.10 (t, J = 4.7 Hz, 4H, 
2×CH2), 3.83 (t, J = 4.7 Hz, 4H, 2×CH2), 3.76 – 3.58 (m), 3.52 (t, J=5.1, 2H), 3.39 (q, J=5.3, 
2H), 3.17 (qd, J=7.4, 4.3, 2H) 2.66 – 2.48 (m, 8H, 4×CH2 ), 0.96 (t, J=7.9, 18H, 
2×Si(CH2CH3)3), 0.56 (q, J = 7.9 Hz, 12H, 2×Si(CH2CH3)3). 
13C-NMR (151 MHz, CDCl3): δ (ppm): 175.9 (C=O), 162.9 (2×Carom), 106.0 (CH2C≡C), 105.7 
(2×CaromH), 104.0 (CaromH), 82.9 (CH2C≡C), 70.6 (CH2), 70.6 (CH2), 70.5 (CH2), 70.3 (CH2), 
70.1 (CH2), 69.8 (CH2), 69.6 (CH2), 69.5 (CH2), 69.2 (CH2), 67.5 (CH2), 55.4 (CaromCH2N3), 
39.9 (OCH2CH2NHCO), 39.3 (OCH2CH2NHCO), 35.0 (2×CH2CH2C≡C), 33.3 (2×CH2CO), 
15.6 (2×CH2CH2C≡C), 7.5 (2×Si(CH2CH3)3), 4.4 (2×Si(CH2CH3)3). 
HR-MS (ESI): C58H95O14N8Si2 [M+H]









5-Iodo-2′-deoxyuridine (5.0 g, 14.12 mmol, 1.0 eq.) was dissolved in dry DMF (80 mL). 
DIPEA (12.3 mL, 9.13 g, 70.60 mmol, 5.0 eq.), 1,7-octadiyne (2.81 mL, 2.25 g, 21.18 mmol, 
1.5 eq.) and bis(triphenylphosphine)palladium(II) dichloride (991 mg, 1.41 mmol, 10 mol%) 
were added. The solvent was degassed by four freeze pump thaw cycles and copper (I) iodide 
(538 mg, 2.82 mmol, 20 mol%) was added. The reaction was stirred over night at room 
temperature and the solvent was removed in vacuo. The residue was taken up in EtOAc (50 
mL), washed with brine (3×50 mL) and the organic layer was dried over MgSO4 and filtered. 





After concentration in vacuo, the crude product was purified by flash column chromatography 
(Silica, i-Hex/EtOAc 1/0 → 0/1) to provide X as colourless solid (950 mg, 2.86 mmol, 21 %). 
1H-NMR (400 MHz, DMSO-d6): δ (ppm): 11.10 (bs, 1H, NH), 8.07 (s, 1H, C6H), 6.10 (t, 1H, 
J = 6.5 Hz, C1’H), 5.22 (bd, 1H, J = 4.0 Hz, OH), 5.06 (t, 1H, J = 4.8 Hz, OH), 4.23 (m, 1H, 
C3’H), 3.78 (dd, 1H, J= 6.6, 3.5 Hz, C4’H), 3.55-3.65 (m, 2H, C5’H), 2.75 (m, 1H, C≡CH), 
2.38 (m, 2H, C≡CCH2), 2.19 (m, 2H, HC≡CCH2), 2.11 (m, 2H, C2’H), 1.57 (m, 4H, 2×CH2). 
13C-NMR (101 MHz, DMSO-d6): δ (ppm): 161.5 (C4), 149.4 (C2), 142.6 (C6), 98.9 
(C≡CCH2), 92.8 (C≡CCH2), 87.4 (C4’), 84.5 (C1’), 84.2 (HC≡C), 72.9 (C5), 71.3 (C≡CH), 
70.1 (C3’), 60.9 (C5’), 39.9 (C2’), 27.1 (C≡CCH2CH2), 27.0 (C≡CCH2CH2), 18.2 (C≡CCH2), 
17.1 (HC≡CCH2). 
HR-MS (ESI): C17H21O5N2 [M+H]







5-(Octa-1,7-diynyl)-2’-deoxyuridine (951 mg, 2.86 mmol, 1.0 eq.) was dissolved in dry 
pyridine (10 mL) under N2 atmosphere. DMAP (35 mg, 286 µmol, 10 mol%) was added and 
the reaction was cooled to 0 °C. 4,4′-Dimethoxytrityl chloride (1.45 g, 4.29 mmol, 1.5 eq.) was 
added portion-wise over 45 minutes and the reaction was further stirred at room temperature 
for 5 hours. The reaction was quenched by addition of methanol (15 mL) and concentrated in 
vacuo. The residue was purified by flash column chromatography (Silica, DCM/MeOH with 





0.1 % pyridine, 99/1 → 98/2) to provide 5-(Octa-1,7-diynyl)-5’-O-(4,4’-dimethoxytrityl-)-2’-
deoxyuridine as a yellow oil (1.40 g, 2.21 mmol, 78 %). 
1H-NMR (400 MHz, CD2Cl2): δ (ppm): 7.97 (s, 1H, C6H), 7.45 (dd, 2H, J = 8.6 Hz, 1.5, 
CHarom), 7.36 (dd, 4H, J = 8.5, 1.9 Hz, CHarom), 7.31 (m, 2H, CHarom), 7.24 (m, 1H, CHarom), 
6.87 (d, 4H, J = 8.5 Hz, CHarom), 6.29 (dd, 1H, J = 7.7, 5.8 Hz, C1’H), 4.55 (m, 1H, C3’H), 
4.08 (dd, 1H, J = 6.2, 3.3 Hz, C4’H), 3.79 (s, 6H, 2×OCH3), 3.34 (d, 2H, J = 3.3 Hz, C5’H), 
2.46 (m, 1H, C2’H), 2.28 (m, 1H, C2’H), 2.15 (td, 2H, J = 7.1, 1.6 Hz, CH2C≡C), 2.07 (td, 2H, 
J = 6.8, 2.5 Hz, CH2C≡CH), 1.96 (t, 1H, J = 2.5 Hz, C≡CH), 1.42 (m, 4H, 2×CH2). 
13C-NMR (101 MHz, CD2Cl2): δ (ppm): 163.3, 163.0, 153.9, 153.8, 149.1, 146.2, 146.0, 140.4, 
140.0, 139.9, 134.4, 134.3, 132.4, 132.2, 131.3, 128.2, 128.0, 117.6, 105.0, 98.6, 91.3, 90.9, 
89.6, 88.4, 76.5, 75.6, 72.6, 67.9, 59.6, 45.7, 30.0, 29.7, 21.2, 20.1.  
HR-MS (ESI): C38H39O7N2 [M+H]








5-(Octa-1,7-diynyl)-5’-O-(4,4’-dimethoxytrityl-)-2’-deoxyuridine (200 mg, 315,1 µmol, 1.0 
eq.) was poured in a Schlenk tube previously baked over night at 150 °C and filled with argon. 
Dry DCM (1.2 mL) was added and the solvent was degassed by three freeze pump thaw cycles. 
Triisopropyl tetrazolide (27 mg, 157.6 µmol, 0.5 eq.) and 2-cyanoethyltetraisopropyl 
phosphoramidite (120 µL, 114 mg, 378.1 µmol, 1.2 eq.) were added. The reaction was stirred 





at room temperature for 24 hours and the solvent was removed in vacuo. The crude mixture 
was purified by flash column chromatography with degassed eluent (Silica, i-Hex/EtOAc 1/3 
with 1 % pyridine) under argon atmosphere to provide X as white solid (143 mg, 171.27 µmol, 
54 %).  
13P NMR (80.9 MHz, CD2Cl2): δ (ppm): 149.9, 149.6. 
HR-MS (ESI): C47H56O8N4P [M+H]









3´,5´-O-(di-tert-butylsilanediyl)-2´-O-tert-butyldimethylsilyl-cytidine 43 (5.0 g, 10.04 mmol, 
1.0 eq.) was dissolved in dry acetonitrile (100 mL). To the solution were added iodine (5.10 g, 
20.09 mmol, 2.0 eq.) and Ammonium Cerium(IV) Nitrate (11.01 g, 20.09 mmol, 2.0 eq.) at 
room temperature. After being stirred for 2.5 hours at 50 °C, the reaction mixture was cooled 
down to room temperature. To the solution was added ethyl acetate (200 mL) and it was 
subsequently washed with Na2S2O3 saturated aqueous solution/NaHCO3 saturated aqueous 
solution (200 mL, 1/1). The organic phase was dried over Na2SO4, filtered and concentrated in 
vacuo.  The residue was purified by flash column chromatography (Silica, i-Hex/EtOAc 1/0 → 
7/3) to provide 5-iodo-3´,5´-O-(di-tert-butylsilanediyl)-2´-O-tert-butyldimethylsilyl-cytidine  
44 (3.07 g, 4.92 mmol, 49 %).  





1H-NMR (400 MHz, CDCl3): δ (ppm): 7.88 (s, 1H), 5.65 (s, 1H), 4.50 (dd, J = 8.4, 4.2 Hz, 
1H), 4.42 (d, J = 4.7 Hz, 1H), 4.17 – 4.01 (m, 3H), 1.09 (s, 9H), 1.06 (s, 9H), 0.96 (s, 9H), 0.22 
(s, 3H), 0.17 (s, 3H).  
13C-NMR (101 MHz, CDCl3): δ (ppm): 165.6, 155.3, 148.8, 96.4, 77.1, 76.3, 75.9, 68.7, 57.6, 
28.0, 27.7, 26.5, 23.6, 21.3, 19.2, -4.0, -4.6. 
IR: νmax (cm-1): 2933, 2858, 1646, 1616, 1472, 1058, 828, 776 cm-1.  
HR-MS (ESI): C23H43IN3O5Si2








5-iodo-3´,5´-O-(di-tert-butylsilanediyl)-2´-O-tert-butyldimethylsilyl-cytidine 44 (1.50 g, 2.41 
mmol, 1.0 eq.), p-nitrophenethyl alcohol (2.01 mg, 12.03 mmol, 5.0 eq.), Pd2(CH3CN)2Cl2 (63 
mg, 0.24 mmol, 10 mol%) and diisopropylethylamine (840 µL, 4.82 mmol, 2.0 eq.) were added 
in a high pressure glass autoclave. The autoclave was flushed with CO three times to remove 
residual air and subsequently the reaction was stirred at a CO pressure of 3.5 bar at 80 °C for 
16 hours. The CO was expelled and the residue was purified by flash column chromatography 
(Silica, DCM/MeOH, 100/0 → 98/2) to afford compound 5-(2-(para-
nitrophenyl)ethoxycarbonyl)-3´,5´-O -(di-tert-butylsilanediyl)-2´-O-tert-butyldimethylsilyl-
cytidine 45 (876 mg, 1.26 mmol, 52 %).  
1H-NMR (599 MHz, CDCl3): δ (ppm): 8.28 (s, 1H), 8.24 – 8.19 (m, 2H), 7.88 – 7.80 (s, br, 
1H), 7.41 (d, J = 8.5 Hz, 2H), 6.61 – 6.41 (s, br, 1H), 5.69 (s, 1H), 4.58 – 4.48 (m, 2H), 4.32 
(d, J = 4.0 Hz, 1H), 4.31 – 4.24 (m, 1H), 3.81 (dd, J = 9.3 Hz, 1H), 3.74 (dd, J = 9.7, 4.1 Hz, 





1H), 3.14 (t, J = 6.9 Hz, 2H), 1.04 (s, 1H), 1.02 (s, 9H), 1.01 (s, 9H), 0.95 (s, 9H), 0.24 (s, 3H), 
0.16 (s, 3H).  
13C-NMR (151 MHz, CDCl3): δ (ppm): 164.5, 163.5, 153.6, 147.3, 147.2, 144.8, 129.6, 124.2, 
95.3, 94.4, 75.6, 75.3, 74.8, 68.0, 64.4, 35.1, 27.6, 27.4, 27.1, 26.0, 22.9, 20.5, 18.3, -4.2, -4.7. 
IR: νmax (cm-1): 3403, 3187, 2934, 2860, 1714, 1677, 1643, 1516, 1472, 1343, 1311, 1250, 
1156, 1130, 1118, 1081, 1059, 830, 780 cm-1.  
HR-MS (ESI): C32H51N4O9Si2









butyldimethylsilyl-cytidine 45 (350 mg, 505.1 µmol, 1.0 eq.) was dissolved in dry pyridine 
(10.5 mL). To the solution was added p-methoxybenzoyl chloride (140 µL, 1.03 mmol, 2.0 eq.) 
at room temperature. The reaction mixture was put on a pre-heated oil bath at 90 °C and stirred 
for 4 hours. The reaction mixture was cooled down to room temperature and EtOAc (70 mL) 
was added. The residue was washed with brine (3×15 mL) and the organic phase was dried 
over Na2SO4, filtered and concentrated in vacuo. The crude product was purified by flash 
column chromatography (Silica, iHex/DCM, 50/50 → 0/100 and then DCM/MeOH, 100/0 → 
90/10). All the fractions were collected and concentrated in vacuo. The residue was dissolved 
again in DCM (5 mL) and washed with NaHCO3 saturated aqueous solution (3×5 mL). The 
aqueous phase was retro-extracted with DCM (1×5 mL). The combined organic layers were 





dried over Na2SO4, filtered and concentrated in vacuo. The residue was again purified by flash 
column chromatography (Silica, iHex/DCM, 50/50 → 0/100) to provide N4-para-
methoxybenzoyl-5-(2-(para-nitrophenyl)ethoxycarbonyl)-3´,5´-O-(di-tert-butylsilanediyl)-
2´-O-tert-butyldimethylsilyl-cytidine 46 (340 mg, 412.1 µmol, 81%);  
1H-NMR (599 MHz, CDCl3): δ (ppm): 8.48 (s, 1H), 8.22 (d, J = 8.6 Hz, 2H), 7.95 (d, J = 8.4 
Hz, 2H), 7.44 – 7.41 (m, 2H), 7.00 – 6.96 (m, 2H), 5.71 (s, 1H), 4.65 – 4.58 (m, 2H), 4.52 (dd, 
J = 9.2, 5.3 Hz, 1H), 4.36 (d, J = 4.1 Hz, 1H), 4.33 (td, J = 10.1, 5.2 Hz, 1H), 3.89 – 3.87 (m, 
3H), 3.78 (dd, J = 10.0 Hz, 1H), 3.68 (dd, J = 9.8, 4.1 Hz, 1H), 3.19 (t, J = 6.9 Hz, 2H), 1.03 
(s, 9H), 1.01 (s, 9H), 0.95 (s, 9H), 0.26 (s, 3H), 0.17 (s, 3H). 
13C-NMR (151 MHz, CDCl3): δ (ppm):165.3, 163.6, 163.0, 160.1, 152.9, 147.9, 147.3, 144.5, 
130.1, 129.6, 126.0, 124.2, 114.3, 96.6, 94.5, 77.4, 77.2, 76.9, 75.6, 75.0, 68.0, 65.1, 55.7, 34.9, 
29.8, 27.6, 27.0, 26.0, 22.9, 20.5, 18.3, -4.2, -4.7. 
IR: νmax (cm-1): 3283, 2933, 2859, 1682, 1605, 1562, 1515, 1470, 1345, 1309, 1253, 1171, 
1113, 1080, 1058, 999, 835, 794, 780, 751, 734, 687, 653 cm-1.  
HR-MS (ESI): C40H57N4O11Si2
+ [M+H]+, calc.: 825.3557, found: 825.3567. 










In a 50 mL polypropylene tube, N4-para-methoxybenzoyl-5-(2-(para-
nitrophenyl)ethoxycarbonyl)-3´,5´-O-(di-tert-butylsilanediyl)-2´-O-tert-butyldimethylsilyl-
cytidine 46 (269 mg, 326.0 µmol, 1.0 eq.) was dissolved in dry DCM (8.06 mL) and dry 
pyridine (3.25 mL). To the solution were added pyridine hydrofluoride (~70% hydrogen 
fluoride, 118 µL, 4.92 mmol, 15.0 eq.) at 4 °C. After being stirred for 30 minutes at 4 °C, 
methoxytrimethylsilane (3.2 mL) was added. After being further stirred for 1 hour at room 
temperature, the reaction mixture was concentrated in vacuo. The residue was purified by flash 
column chromatography (Silica, DCM/MeOH, 100/0 → 98/2) to obtain N4-para-
methoxybenzoyl-5-(2-(para-nitrophenyl)ethoxycarbonyl)- 2´-O-tert-butyldimethylsilyl-
cytidine 47 (198 mg, 289.1 µmol, 89%). 
1H-NMR (800 MHz, DMSO-d6): δ (ppm): 11.47 (s, 1H), 9.38 (s, 1H), 8.14 (d, J = 8.7 Hz, 2H), 
7.87 (d, J = 8.8 Hz, 2H), 7.58 (d, J = 8.7 Hz, 2H), 7.09 (d, J = 8.8 Hz, 2H), 5.70 (d, J = 1.4 Hz, 
1H), 5.36 (t, J = 4.3 Hz, 1H), 5.06 (d, J = 5.6 Hz, 1H), 4.47 (dt, J = 10.8, 6.7 Hz, 2H), 4.16 (dd, 
J = 4.0, 1.4 Hz, 1H), 4.05 – 3.99 (m, 2H), 3.91 – 3.88 (m, 1H), 3.85 (s, 3H), 3.71 – 3.66 (m, 
1H), 3.13 – 3.09 (m, 2H), 0.90 (s, 9H), 0.14 (s, 3H), 0.10 (s, 3H). 
13C-NMR (201 MHz, DMSO-d6): δ (ppm): 164.9, 163.5, 163.0, 159.8, 153.2, 149.5, 146.4, 
146.2, 130.2, 129.8, 125.5, 123.4, 114.2, 98.6, 91.2, 83.3, 76.5, 67.1, 64.9, 58.5, 55.6, 33.8, 
25.8, 18.0, -4.7, -4.8.  
IR: νmax (cm-1): 3500, 3259, 2954, 2931, 2858, 2252, 1669, 1639, 1605, 1518, 1429, 1346, 
1323, 1253, 1174, 1109, 1087, 1030, 911, 882, 841, 782, 732, 698 cm-1.  














4,4´-dimethoxytritylchloride (2.03 g, 6.00 mmol, 1.0 eq.) was dissolved in dry DCM (20 mL). 
To the solution was added silver triflate (1.54 g, 6.00 mmol, 1.0 eq.) at room temperature to 
prepare 4,4´-dimethoxytrityl triflate salt. After being stirred for 1.5 hours, the 4,4´-
dimethoxytrityl triflate salt solution (1.20 mL, 0.36 mmol, 1.5 eq.) was added to a solution of  
N4-para-methoxybenzoyl-5-(2-(para-nitrophenyl)ethoxycarbonyl)- 2´-O-tert-
butyldimethylsilyl-cytidine 47 (165 mg, 241.0 µmol) in dry DCM/dry pyridine (4.8 mL, 1/1) 
at room temperature. After being stirred for 1.5 hours, additional solution of 4,4´-
dimethoxytrityl triflate salt (0.4 mL, 0.12 mmol, 0.5 eq.) was added to the reaction mixture and 
further stirred for 19.5 hours. DCM (20 mL) was added to the solution and washed with 
NaHCO3 saturated aqueous solution (3×20 mL). The aqueous phase was extracted again with 
DCM (1×20 mL). The combined organic layers were dried over Na2SO4, filtered and 
concentrated in vacuo. The residue was purified by flash column chromatography (Silica, i-
Hex/EtOAc 1/0 → 1/1) to afford compound N4-para-methoxybenzoyl-5-(2-(para-
nitrophenyl)ethoxycarbonyl)- 5´-O-(4,4´-dimethoxytrityl)-2´-O-tert-butyldimethylsilyl-
cytidine 48 (226 mg, 228.9 µmol, 95%).  
1H-NMR (800 MHz, DMSO-d6): δ (ppm): 11.44 (s, 1H), 8.70 (s, 1H), 8.07 (d, J = 8.7 Hz, 2H), 
7.88 (d, J = 8.9 Hz, 2H), 7.43 (d, J = 7.6 Hz, 2H), 7.31 – 7.26 (m, 6H), 7.23 – 7.20 (m, 3H), 
7.09 (d, J = 8.9 Hz, 2H), 6.88 – 6.84 (m, 4H), 5.77 (d, J = 1.9 Hz, 1H), 5.11 (d, J = 6.4 Hz, 





1H), 4.27 (dd, J = 4.6, 2.0 Hz, 1H), 4.17 – 4.12 (m, 1H), 4.01 – 3.97 (m, 1H), 3.86 (s, 3H), 3.84 
– 3.81 (m, 1H), 3.71 (s, 3H), 3.70 (s, 3H), 3.62 – 3.57 (m, 1H), 3.39 – 3.37 (m, 1H), 3.22 (dd, 
J = 10.9, 4.8 Hz, 1H), 2.53 – 2.52 (m, 1H), 2.48 – 2.46 (m, 1H), 0.90 (s, 9H), 0.14 (s, 3H), 0.09 
(s, 3H). 
13C-NMR (201 MHz, DMSO-d6): δ (ppm): 164.2, 163.8, 163.0, 159.9, 158.1, 158.1, 153.2, 
146.2, 145.7, 144.7, 135.3, 135.3, 130.0, 129.9, 129.8, 129.7, 127.9, 127.8, 127.7, 127.6, 125.3, 
123.4, 123.4, 114.3, 114.2, 113.2, 99.6, 91.9, 85.5, 82.1, 76.1, 68.6, 64.2, 62.4, 55.6, 55.0, 40.0, 
39.9, 39.9, 39.8, 39.8, 39.7, 39.7, 39.6, 39.6, 39.5, 39.5, 39.4, 39.3, 39.2, 33.5, 25.8, 18.0, -4.7, 
-4.9.  
IR: νmax (cm-1): 3290, 3078, 2954, 2930, 2856, 2280, 1716, 1679, 1606, 1558, 1511, 1465, 
1346, 1309, 1249, 1174, 1116, 1085, 1034, 836, 795 cm-1.  
HR-MS (ESI): C53H59N4O13Si
+ [M+H]+, calc.: 987.3842, found: 987.3864. 












dimethoxytrityl)-2´-O-tert-butyldimethylsilyl-cytidine 48 (152 mg, 154 µmol, 1.0 eq.) was 
dissolved in degassed dry DCM (1.5 mL). To the solution were added diisopropylethylamine 
(107 µL, 61.6 µmol, 4.0 eq.) and 2-cyanoethyl N,N-diisopropylchlorophosphoramidite (138 
µL, 61.6 µmol, 4.0 eq.) at room temperature. After being stirred for 2 hours, DCM (10 mL) 
was added and the residue was washed with NaHCO3 saturated aqueous solution (2×10 mL) 
and brine (1×20 mL). The organic phase was dried over Na2SO4, filtered and concentrated in 
vacuo. The residue was purified by flash column chromatography with degassed eluent (Silica, 
i-Hex/EtOAc 1/1) under argon atmosphere to afford caC amidite 42 (137 mg, 115.4 µmol, 
75%) as a diastereo mixture. 
1H-NMR (400 MHz, C6D6): δ (ppm): 12.00 (d, J = 55.4 Hz, 1H), 9.25 (s, 1H), 8.13 (d, J = 8.5 
Hz, 2H), 7.84 – 7.78 (m, 2H), 7.70 – 7.63 (m, 2H), 7.50 (dt, J = 8.7, 6.4 Hz, 4H), 7.23 (t, J = 
7.7 Hz, 2H), 7.10 – 7.03 (m, 1H), 6.90 – 6.79 (m, 4H), 6.62 – 6.49 (m, 4H), 6.01 (s, 1H), 5.02 
– 4.88 (m, 1H), 4.72 – 4.50 (m, 2H), 3.98 (dd, J = 22.0, 10.8 Hz, 1H), 3.85 – 3.60 (m, 2H), 
3.45 (dt, J = 10.3, 6.8 Hz, 1H), 3.37 (t, J = 3.6 Hz, 7H), 3.35 – 3.23 (m, 2H), 3.13 (d, J = 3.0 
Hz, 4H), 3.00 – 2.68 (m, 2H), 2.21 (d, J = 31.5 Hz, 2H), 1.15 (d, J = 11.1 Hz, 9H), 1.04 – 0.91 
(m, 12H), 0.88 (d, J = 6.8 Hz, 3H), 0.61 (s, 3H). 





13C-NMR (101 MHz, C6D6): δ (ppm): 159.3, 159.3, 159.3, 147.1, 145.3, 144.9, 136.3, 135.9, 
131.0, 130.9, 130.9, 130.3, 129.9, 129.8, 129.7, 129.1, 127.3, 123.7, 123.6, 123.6, 114.2, 113.7, 
113.7, 113.6, 113.5, 76.0, 64.4, 55.0, 55.0, 54.9, 54.9, 54.8, 54.8, 43.2, 43.1, 34.4, 26.5, 26.4, 
24.8, 24.8, 24.7, 24.7, 24.7, 18.6, 18.5, 1.4, -3.3, -4.8. 
31P-NMR (162 MHz, C6D6): δ (ppm): 153.0, 149.3. 
IR: νmax (cm-1): 2964, 2961, 1681, 1606, 1560, 1511, 1469, 1346, 1306, 1252, 1176, 1118, 
4082, 1034, 836, 794.  
HR-MS (ESI): C62H76N6O24PSi
+ [M+H]+, calc.: 1187.4921, found: 1187.494





4.3 Oligonucleotide synthesis 
4.3.1 General information 
The oligodeoxynucleotide strands containing only the canonical bases (d)A, (d)C, (d)G, d(T) 
and U were purchased from Sigma Aldrich and were used without further purification. The 
synthesis of both DNA and RNA strands containing special bases was performed on an Applied 
Biosystems Incorporated 394 automated synthesizer by the phosphoramidite method. All the 
strands were synthesized on a 1 μmol scale using CPG resin. The synthesis and the coupling 
efficiency were assessed by monitoring the trityl cation absorbance (498 nm) during the 
deblocking step. Dry acetonitrile (<10 ppm H2O, Roth) was used as solvent for all the 
phosphoramidites. The identification of the synthesized strands was achieved by MALDI-TOF 




4.3.2 Synthesis and deprotection of oligodeoxynucleotides containing C8-
alkyne-dU 
The ODN syntheses were performed on pre-loaded CPG resin (N6-Bz-dA or N2-dmf-dG or  N4-
Bz-C or dT) from Link Technologies. Phosphoramidites (N6-Bz-dA, N2-dmf-dG, N4-Bz-C and 
dT ) were obtained from Sigma Aldrich and the coupling time was 5 minutes. The C8-alkyne-
dU phosphoramidite was coupled for 10 minutes. 
The synthesizer was equipped with the following solutions and reagents: 
Phosphoramidites: 0.10 M  in acetonitrile;  
Activator: 0.25 M 5-[3, 5-bis(trifluoromethyl)phenyl]-1H-tetrazole in acetonitrile (solution 
from Sigma-Aldrich);  
Deblock: 3% (v/v) dichloroacetic acid in DCM;  
Oxidation: 25 mM iodine in 65:30:5 (v/v) acetonitrile: H2O:lutidine;  
Capping A: 20:50:30 (v/v) acetic anhydride:acetonitrile:lutidine;  
Capping B: 20% (v/v) N-methylimidazol in acetonitrile. 





After the synthesis, the solid support was dried under high vacuum for 10 minutes and 
transferred in a 1.5 mL Eppendorf tube. The cleavage of the strands off the solid support and 
the removal of all the protecting groups was achieved by incubation in 500 µL of a freshly 
prepared 1:1 mixture of 40% aqueous ammonia and 28% aqueous methylamine (AMA) at 65 
°C for 10 minutes. After cooling to room temperature, the resulting solution was centrifuged 
for 15 minutes at the speed of 13000 rpm. The supernatant was removed and the pellet was 
washed with ddH2O, centrifuged again for 15 minutes at the speed of 13000 rpm and its 
supernatant was also transferred. This operation was repeated one more time and the combined 
supernatant were concentrated by centrifugal evaporation. The resulting pellet was dissolved 




4.3.3 Synthesis and deprotection of oligonucleotides containing caC  
The ON synthesis were performed on pre-loaded CPG resin (N4-Ac-C or N2-dmf-G) from Link 
Technologies. Phosphoramidites (N6-Bz-A, N2-dmf-G, N4-Ac-C and U) were obtained from 
Glen Research or Link Technologies and the coupling time was 10 min. The caC 
phosphoramidite 42 was coupled for 20 minutes. The synthesizer was equipped with the 
following solutions and reagents: 
- Phosphoramidites: 0.15 M in acetonitrile;  
- Activator: 0.25 M 5-[3,5-bis(trifluoromethyl)phenyl]-1H-tetrazole in acetonitrile (solution 
from Sigma-Aldrich); 
- Deblock:15% (v/v) dichloroacetic acid in DCM;  
- Oxidation: 25 mM iodine in 65:30:5 (v/v) acetonitrile:H2O:lutidine;  
- Capping A: 20:50:30 (v/v) acetic anhydride:acetonitrile:pyrdine;  
- Capping B: 20% (v/v) N-methylimidazol in acetonitrile. 
After the synthesis, the solid support was dried in high vacuum for at least 30 min. Then the 
pre-dried solution of DBU-ACN (1 mL, 1:9, v/v) was flew through the solid support over 1-3 
minutes using a disposable syringe followed by washing with d acetonirile and dry in high 
vacuum. Then the solid support was transferred into a 1.5 mL Eppendorf tube. To the tube, 
pre-dried DBU-THF (1 mL, 1:9, v/v) solution was added and reacted for 2 hours on a preheated 
thermomixer (45 °C) followed by washing with dry THF. The supernatant was removed and 





the solid support was dried at room temperature. To the tube, absolute ethanol (200 µL) and 
28% NH4OH aqueous solution (600 µL) were added at room temperature. The tube was then 
placed on a preheated thermomixer (55 °C) and mixed for 18 hours. The reaction was then 
cooled down to room temperature and the supernatant was transferred to a 2.0 mL Eppendorf 
tube followed by the washing of the CPG resins with ddH2O-EtOH (3:1, v/v) solution (3×200-
300 µL). The resulting solution was dried down using a centrifugal evaporator and 
lyophilisation. Into the tube, 100 µL of DMSO and 125 µL of triethylamine trihydrofluoride 
solution were added. The tube was then placed on a preheated thermomixer (65 °C) and mixed 
for 1.5 hours. The tube was placed on ice and 25 µL of 3 M NaOAc aqueous solution was 
added followed by the addition of n-butanol (1 mL). The resulting solution was then stored in 
-80 °C over night. The resulting solution was centrifuged for 1 hour at 4 °C at the speed of 
21130 rpm. The supernatant was removed and the residue was washed once with EtOH-ddH2O 
(4:1, v/v) and centrifuged again for 30 minutes with the same conditions. The supernatant was 
removed and the residue was dried at room temperature for at least 30 minutes. The residue 
was dissolved in 0.5 M triethylammonium acetate buffer (pH 7.0) and was proceeded to HPLC 
analysis, purification, or stored at -20 °C freezer.





4.4 Click protocols 
4.4.1 Oligodeoxyribonucleotide functionalization, characterisation and 
purification 
Click reaction on ODN 
 
The desired amount (in nmol) of oligodeoxynucleotide in solution was aliquoted in a 1.5 mL 
Eppendorf tube and concentrated until dryness with a Speedvac. The ODN was subsequently 
resuspended in ddH2O with a volume corresponding to a concentration of 10 mM. The linker 
(in solution in tBuOH/DMSO 3:1) to be conjugated with the ODN and all the reagents were 
added and the mixture was degassed using argon. The tube was placed in a thermomixer (25 
°C) and shaken for 4 hours at 950 rpm. The reaction was stopped by diluting the mixture in 
ddH2O, frozen in liquid nitrogen and immediately lyophilized. The residue was resuspended in 
ddH2O in order to be analysed (MALDI-ToF and RP-HPLC) and purified (preparative RP-
HPLC). The percentage of completion of the reaction was determined by integration of the 
HPLC trace of the crude product at 260 nm. 
 
TES alkyne protected group removal  
 
The ODN conjugated as described in the previous section to a linker bearing an alkyne 
protected by a triethylsilyl protecting group were resuspended in a NaF solution (400 mM in 
water) in a 1.5 mL Eppendorf tube and incubated in a thermomixer for 48 hours, at 950 rpm 
and 40 °C. After cooling down, the mixture was filtered and washed with ddH2O (3×500 µL) 
on an Amicon Ultra-0.5 mL centrifugal membrane filter with a molecular weight cut-off of 3 
kDa. The residue was resuspended in ddH2O, analysed (MALDI-ToF and RP-HPLC), 









4.4.2 Template-assisted double conjugation 
The functionalized oligodeoxynucleotide probes which comprised one ODN bearing two 
azides and two ODNs bearing one alkyne (1 nmol each) and the template strand (1 nmol) were 
combined in a 1.5 mL Eppendorf tube and concentrated until dryness in a Speedvac. The ODNs 
were resuspended in NaCl solution (0.2 M in water, 100 µL) and annealed in a thermomixer at 
95 °C for 15 minutes without shaking. The temperature was then gradually decreased by 10 °C 
every 15 minutes until 25 °C was reached. A click catalyst Master Mix solution was prepared 
as following: 
 
Master Mix preparation: final volume = 50 µL 




[Final] in 0.2 M 
aqueous NaCl 
Stoichiometry 
CuSO4  40 mM 5 µl 4 mM 1 
BTTAA 50 mM 30 µl 30 mM 7.5 
Na ascorbate 133 mM 15 µl 40 mM 10 
 
10 µL of this Master Mix was added to the oligonucleotides at the following equivalents per 
click reaction: 
- CuSO4: 20 eq. 
- Na ascorbate: 200 eq. 
- BTTAA: 140 eq. 
 
The reaction mixture was degassed with argon for 1 to 2 minutes and shaken in a thermomixer 
at room temperature and 300 rpm for 3 hours. The reaction was stopped by diluting the mixture 
in ddH2O and was filtered and washed with ddH2O (3×500 µL) on an Amicon Ultra-0.5 mL 
centrifugal membrane filter with a molecular weight cut-off of 3 kDa. The conjugated 
oligonucleotides were lyophilized and suspended again in ddH2O prior analysis by PAGE.





4.5 Biochemical experiments 
4.5.1 Melting Curve Experiments 
Melting profiles were measured on a Jasco V-650 spectrometer using quartz glass cuvettes 
with 10.0 mm path length. Final samples contained the two oligonucleotide of which the 
dissociation-characteristics are to be assessed each at 2 µM concentration, 0.2 M NaCl aqueous 
solution, 10 mM aqueous sodium phosphate buffer in a final volume of 400 µL. Measurements 
were repeated at least three times per sample. Before the measurement, the oligonucleotides 
were hybridized at 95 °C for 5 minutes followed by cooling down to 4 °C over a period of 40 
minutes. For the UV-measurements the solutions were covered with silicon oil and tightly 
plugged. Absorbance was recorded in the forward and reverse direction at temperatures from 
15 °C to 85 °C at 0.1 °C/3 seconds. At least three denaturing and renaturing ramps were 
performed and averaged for evaluation of the melting temperature. Tm values were calculated 
as the zero-crossing of 2nd derivate of the 349 nm background-corrected change in 




4.5.2 DNA PAGE 
ODN strands and products from the click conjugations were analysed by 20% denaturing 
polyacrylamide gel electrophoresis on 20 x 20 cm gels of 1 mm thickness. The samples to 
analyse were prepared in order to contain approximately 300 ng of ODN for the 11 mer strands 
and 150 ng for the 15 mer strands in 5 µL of ddH2O. To each sample was added 5 µL of loading 
buffer prepared as described in the recipe table. The gels were run in TBE buffer (see below 
recipe table) at 40 °C applying a constant current of 40 mA per gel (maximum 1000 V) for 
about 5-6 hours. The gels were stained with SYBR® green II for 30 minutes (in ddH2O, 100 











Loading buffer - 875 µL 8 M Urea 
- 25 µL ddH2O 
- 100 µL 10× TBE buffer 
- 120 mg Ficoll 400 
- ≈ 1 mg bromophenol blue 
Polyacrylamide gel - 32 mL Rotiphorese® sequencing gel concentrate  
- 4 mL 8 M  urea  
- 4 mL 10 x TBE buffer  
- 200 μL APS 
- 20 μL TEMED 
TBE 10× buffer - 108 g Tris 
- 55 g boric acid 
- 9.3 g EDTA 
- 1 L final volume with ddH2O 




4.5.3 Enzymatic digestion of ON 
1 nmol of ONs were dissolved in ddH2O (35 µL). Subsequently it was added an aqueous 
solution (7.5 µL) of 480 µM ZnSO4, containing 42 units Nuclease S1, 5 units Antarctic 
phosphatase and the digestion mixture was incubated at 37 °C for 3 hours in a thermomixer. 
After addition of a 520 µM [Na]2-EDTA solution (7.5 µL) containing 0.2 units snake venom 
phosphodiesterase I, the sample was further incubated for 3 hours at 37 °C. The total volume 
was 50 µL and the digested product was filtered on paper using an AcroPrepTM Advance 96 
filter plate 0.2 µm Supor® from Pall Life Sciences by centrifugation at 4 °C at 14000 rpm for 
30 minutes. The samples were stored at -20 °C until analysis LC-MS/MS as described in the 
next section.





4.6- UHPLC-MS analysis 
The analysis of the digested RNAs were performed by LC-ESI-MS on a Thermo Finnigan LTQ 
Orbitrap XL and were chromatographed by a Dionex Ultimate 3000 HPLC system with a flow 
of 0.15 mL/min over an Interchim Uptisphere120A-3µm-HDO C18 column. The column 
temperature was maintained at 30 °C. Eluting buffers were buffer A (2 mM HCOONH4 in 
ddH2O (pH 5.5)) and buffer B (2 mM HCOONH4 in ddH2O/MeCN 20/80 (pH 5.5)). The 
gradient for all samples was from 100% to 94% buffer A over 55 min. The elution was 
monitored at 260 nm (Dionex Ultimate 3000 Diode Array Detector). The chromatographic 
eluent was directly injected into the ion source without prior splitting. Ions were scanned by 








(d)A (deoxy)Adenine/Adenosine (depending on context) 
(d)C (deoxy)Cytosine/Cytidine (depending on context) 
(d)G (deoxy)Guanine/Guanosine (depending on context) 
(d)T (deoxy)Thymine/Thymidine (depending on context) 
(d)U (deoxy)Uracil/Uridine (depending on context) 
°C Degree Celsius (temperature) 
Ac Acetyl 
ACN Acetonitrile  
AMA 1:1 mixture of 40% aqueous ammonia/28% aqueous methylamine 
APS Ammonium persulfate 
Boc2O Di-tert-butyl dicarbonate 





caC 5-carboxy cytosine 
CAN Ceric ammonium nitrate 
COSY Correlation spectroscopy (2D NMR) 
CPG Controlled pore glass 















DNA Deoxyribonucleic acid 
e.g. Latin “exempli gratia”, meaning: for example 
EDTA Ethylenediaminetetraacetate 
eq. Equivalent(s) 
ESI Electrospray ionization 
et al. Et alii (latin = and others) 
EtOAc Ethylacetate 
EtOH Ethanol 
FISH Fluorescence in situ hybridization 
FTICR Fourier-transform ion cyclotron resonance 
g Gram, 10–3 kg 
HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-
b]pyridinium 3-oxid hexafluorophosphate 
HMBC Heteronuclear multiple-bond correlation spectroscopy 
HPA Hydroxypicolinic acid 
HPLC High-pressure liquid chromatography/High-performance liquid 
chromatography 
HR High-resolution 
HRMS High-resolution mass spectrometry 
HSQC Heteronuclear single quantum coherence/correlation 
Hz Herz 
iHex Isohexane 







J Coupling constant 
kDa Kilodalton 
L Liter(s) 
LC Liquid chromatography 
m Meter(s) 
M Molar concentration 
m Multiplet 
m/z Mass to charge ratio 




mRNA Messenger RNA 
MS Mass spectrometry 
NaOAc Sodium acetate 
NMR Nuclear magnetic resonance 
O(D)N Oligo(deoxyribo)nucleotide 
PAGE Polyacrylamide gel electrophoresis 
PCR Polymerase chain reaction 
PDC Pyridinium dichromate 
pH The negative decimal logarithm of the hydrogen ion activity 
PLA Proximity ligation assay 
ppm Parts per million 
q Quartet 






RCA Rolling circular amplification 
RNA Ribonucleic acid 
ROS Reactive oxygen species  
RP Reversed-phase 











Tm Melting temperature 
Tris Tris(hydroxymethyl)aminomethane 
UHPLC-MS Micro HPLC-MS  
UV Ultraviolet 
v/v Volume per volume 
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